8
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 619-637 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Reconstitution of membrane proteins into lipid monolay er. Two-step transfer technique: from cell to liposome, from liposome to lipid monolayer. GLucK, G., OKUMURA, Y., and SUNAMOTO, J. Chem. Lett., 1995 (11), 1031–102.
  • Effect of exogenous gangliosides on liposome phospholipid bilayer stability. BURKHANOY, S. A., USMANOVA, G. U., and SAATOV, T. S. Dokl Akad Nauk Resp Uzb, 1994(11), 42–43.
  • Modified hydroxyapatite microspheres as immunoadsorbent for plasma perfusion: pre-liminary study. PAUL, W., and SFIARMA, C. P., 5. Colloid Interface Sci., 1995, 174 (1), 224–229.
  • Quantitative assessment of cerebral blood flow measurement using the microsphere model with N-isopropyl-p-(123-I) iodoamphetamine SPECT: simulation analysis for the in-fluence of washout from brain tissue. Onxuao, M., ()DAN°, I., TAICAHASHI, N., and SAKAI, K. Acta Med. Biol. (Niigata), 1995, 43 (3), 165–171.
  • Release of encapsulated proteinase from dehydration-rehydration liposomes by a co-encapsulated phospholipase. PICON, A., GAYA, P., MEDINA, M., and NUNEZ, M. Biotechnol. Lett., 1995, 17 (10), 1051–1056.
  • Determination of binding constants of Ca2+, Na+, and Cl ions to liposomal membranes of dipalmitoylphosphatidylcholine at gel phase by particle electrophoresis. SATOH, K. Biochim. Biophys. Acta, 1995, 1239 (2), 239–248.
  • Synthetic polycations on the surface of negatively charged liposomes. YAROSLAVOV, A. A., Kuutov, V. Y., EFIMOVA, A. A., and IGNATIEV, M. 0. Thin Solid Films, 1995, 265 (1–2), 66–70.
  • Effect of II-carotene, lutein and violaxanthin on structural properties of dipalmitoyl-phosphatidylcholine liposomes as studied by ultrasound absorption technique. WOJTOWICZ, K., and GRUSZECKI, W. 5. Biol. Phys., 1995, 21(1), 73–80.
  • Calcium-dependent binding of uteroglobin (PCB-BP/CCSP) to negatively charged phospholipid liposomes. NORD, M., GUSTAFSSON, J., and LUND, J. FEBS Lett., 1995, 374 (3), 403–406.
  • Studies on biodegradation and rotational use of pesticides. II. Preparation of control release microcapsules using a mechanochemical procedure. MATSUMOTO, Y., and TOTSUKA, Y. Shizuoka ken Shizuoka Kogyo Gijutsu Senta Kenkyu Hokoku, 1995, 40, 55–59.
  • Partitioning of substituted phenols in liposome-water, biomembrane-water, and octanol-water systems. ESCHER, B. I., and SCHWARZENBACFI, R. P. Environ. Sci. Technol., 1995, 30 (1), 260–270.
  • Enhanced adeno-associated virus vector expression by adenovirus protein-cationic liposome complex. ZHOU, H., ZENG, G., ZHU, X., TANG, J., CHE 9, G. HuANG, Q., PENG, T., and Hu, B. Chin. Med. 5. (Beijing, Engl. Ed.), 1995, 108 (5), 332–337.
  • Functional reconstitution of a highly purified It-opioid receptor protein with purified G proteins in liposomes. FAN, L. Q., GIOANNINI, T. L., WouNsKY, T., HILLER, J. M., and SIMON, E. J. 5. Neurochem., 1995, 65 (6), 2537–2542.
  • Influence of ginsenoside-Rbl on the phase transition temperature of the dipalmitoylphos-phatidylcholine liposome. WANG, F., QUAN, W., XII, G., QUAN, Y., XIAN, M., ZHANG, W., WANG, Y., and Wu, G. Jilin Daxue Ziran Kexue Xuebao, 1995 (3), 65–67.
  • Studies on the effects of capsaicin on leakage in egg lecithin (phosphatidyl choline) liposome membranes in vitro. MANDAL, T. K., CHAKRABORTY, B., and DE, A. K. Phytother. Res., 1995, 9 (6), 425–428.
  • Liposome-mediated in vivo ElA gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu. Yu, D., MATIN, A., XIA, W., SORGI, F., HUANG, L., HUNG, M. C. Oncogene, 1995, 11(7), 1383–1388.
  • Antitumor efficacy of taxane liposomes on a human ovarian tumor xenograft in nude athymic mice. SHARMA, A., STRAUBINGER, R. M., OJIMA, I., and BERNACKI, R. J.5. phann. Sci., 1995, 84 (12), 1400–1404.
  • Experimental and clinical trial of degradable starch microspheres (DSM) in treatment of hepatic neoplasm. 2. Clinical study. YAMADA, T. Nippon Igaku Hoshasen Gakkai Zasshi, 1995, 55 (11), 732–738.
  • Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or encapsulated granulocyte-macrophage colony-stimulating factor against intramacro-phage Mycobacterium avium-Mycobacterium intracellulare. ONYEJI, C. 0., NIGHTINGALE, C. H., TESSIER, P. R., NICOLAU, D. P., and Bow, L. My. Infect. Dis., 1995, 172 (3), 810–816.
  • Biodistribution of liposomes after extradural administration in rodents. UMBRAIN, V., ALAFANDY, M., BOURGEOIS, P., D'HAESE, J., BOOGAERTS, J. G., GOFFINET, G., CAMU, F., and LEGROS, F. J. Br. 7. Anaesth., 1995, 75 (3), 311–318.
  • Novel optical measurements approach for the quantitation of liposome immunomigration assays. REEVES, S. G., and DURST, R. A. Anal. Lett. 1995, 28 (13), 2347–2362.
  • Application of evanescent wave scattering to the study of the motion of liposomes near a solid surface. GAIGALAS, A. K., HUBBARD, J. B., PALNT, A. L., and REIPA, V.7. Colloid Interface Sci., 1993, 175 (1), 181–189.
  • Physical stability of liposomes studied by EPR method. GREGORC, K., KRISTL, J., GABRIJELCIC, V., SENTJURC, M., SMID, K. J. Farm. Vestn. (Ljubljana), 1995, 46 (2), 199–126.
  • Chitosan as cell microencapsulation material. Li, T., YANG, J., Cui, R., GAO, R., SONG, J., and SUN, D. Zhongguo Shengwu Yixue Gongcheng Xuebao, 1995, 14(1), 7–10.
  • The rat epididymal fat pad as an implantation site for the study of microcapsule bio-compatibility: validation of the method. PARLSEAU, J. F., LENBLOND, F. A., HAREL, F., LEPAGE, Y., and HALLE, J. P.7. Biomed. Mater. Res., 1995, 29 (11), 1331-1335. Incorporation of polymer microspheres in porous polyurethane vascular grafts. KREITZ, M. R. WEBBER, W. L., GALLETTI, P. NI., and MATHIOWITZ, E. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 79–80.
  • Study of microencapsulation for pituitary transplantation: capsule preparation and in vitro study. CHEN, Z., SAO, Y., GORCZYCA, W., and MOH, G. Artif. Cells, Blood Substitutes Immobilization Biotechnol., 1995, 23 (5), 597–604.
  • Preparation and in-vitro evaluation of sustained-release metaclopramide hydrochloride microspheres. KIHDR, S. H., NIAZY, E. M., and EL SAYED, Y. 7. Microencapsulation, 1995, 12 (6), 651–660.
  • Study of a microencapsulation process of a virucide agent by a solvent evaporation technique. LEGRAND, J., BRUJES, L., GARNELLE, G., and PHALIP, P.7. Microencapsulation, 1995, 12(6), 639–649.
  • Preparation and in vitro dissolution of salbutamol sulfate microcapsules and tabletted microcapsules. YAZAN, Y., DENIIRE, M., and GULER, E. 7. Microencapsulation, 1995, 12 (6), 601–607.
  • Influence of pH adjustment on microcapsules obtained from complex coacervation of gelatin and acacia. DANIELS, R., and NIrrrEaNtAlea, E. M. 7. Microencapsulation, 1995, 12 (6), 591–599.
  • Microspheres of poly(2-hydroxyethyl methacrylate-co-fl-methacryloyloxyethyldeoxycholate) crosslinked with ethylene glycol dirnethacrylate. ORIENTI, I., AIEDEH, K., GIANASI, E., COPPOLA, A., and ZECCH I, V. Pharm. Acta Helv., 1995, 70 (3), 241–246.
  • Production of biodegradable microspheres for sustained delivery of tetracyclines to the periodontal pocket: Formulatory and drug release studies. IVIENEcArn, E., ESPOSITO, E., CORTESI, R., and NASTRUZZI, C. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 794–795.
  • Role of low-molecular-weight polylactide and its copolymer in the acceleration of hydrolysis of PLGA (75:25) microcapsules. SAD, H., and CHIEN, Y. W. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 776–777.
  • Microencapsulation of zidovudine by a novel phase separation technique. MANDAL, T. K., SHEKLETON, NI., WASHINGTON, L., ONYEBUEKE, E., and PENSON, T. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 768–769.
  • Poly(vinyl alcohol) encapsulated porous polymethacrylate microspheres for controlled drug release. SUN, Y. M., and HUANG, C. W. Proc. Int, Symp. Controlled Release Bioact. Mater., 1995, 22, 342–343.
  • Preparation of porous and nonporous biodegradable polymeric hollow microspheres. Caorrs, G., and GWAN, P. T. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 81–82.
  • Pharmaceutical and biological properties of doxorubicin encapsulated in liposomes (L-ADM); the effect of repeated administration on the systemic phagocytic activity and pharmacokinetics. YACHI, K., KIKUCHI, H., Suzuxt, N., ATSUMI, R., AONUMA, M., and KAWATO, Y. Biopharm. Drug Dispos., 1995, 16 (8), 653–667.
  • Poly(adipic anhydride) microspheres for ocular drug delivery. STURESSON, C., CARLFORS, J., and ALBERTSON, LBERTSON. C. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 856-757. Microsphere transport pathways in the rabbit nasal mucosa. HUANG, Y., DONOVAN, M. D. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 622–623.
  • Stabilization of microencapsulated protein vaccines. JOHANSEN, P., MERKLE, H. P., and GANDER, B. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 584–585.
  • The potential application of alginate/chitosan porous microsphere loaded with interleukin-2 in tumor immunotherapy. Lie, L. S., Liu, S. Q., No, S., HELLER, J., and Fitoix, itoix. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 542–543.
  • Effects of y-irradiation on the drug release characteristics of poly(d, 1-lactide) microspheres. Aso, Y., YOSHIOKA, S., OTSUKA, T., and KoiiNiA, S. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 386–387.
  • Targeting of sterically stabilized liposomes to tumors: Control of drug release and therapeutic efficacy. PAPAHADJOPOULOS, D., HONG, K., GABER, M. H., HUANG, S. K., PARK, J. W., and BENZ, C. C. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 67–68.
  • Synthetic sulfonated microspheres as drug delivery carriers. YUAN, S., and HOFFNIAN, A. S. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 26–27.
  • Preparation of a vinyl amine copolymer for the microencapsulation of mammalian cells. YAMAMOTO, Y., and SEFTON, M. V. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1994, 35 (2), 61–26.
  • pH and ionic strength-sensitive microcapsules: effects of dissociable groups on their structure. IVIAKINo, K., UEDA, N., OHTA, R., OHSHIMA, H., KONDO, T Polym. Prepr. (Am. Chem. Soc. Div. Polym. Chem.), 1994, 35 (2), 53–54.
  • Heat-stabilized albumin microspheres as a sustained drug delivery system for the anti-metabolite, 5-fluorouracil. TRUTER, E. J. Artif. Cells, Blood Substitutes, Immobilization Biotechnol., 1995, 23 (5), 579–586.
  • Intranasal immunization with rich toxoid (RT) vaccine encapsulated in polymeric micro-spheres against aerosol challenge. YAN, C., RILL, W., HEWETSON, J., TAMMARIELLO, R., MALLO, R., and KENDE, M. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 39–40.
  • Liposome circulation time and tumor targeting: implications for cancer chemotherapy. GABIZON, A. A. Adv. Drug. Delivery Rev., 1995, 16 (2, 3), 285–294.
  • Pharmacokinetics of long-circulating liposomes. ALLEN, T. M., HANSEN, T. B., and DE MENEZES, D. E. L. Adv. Drug Delivery Rev., 1995, 16 (2, 3), 267–284.
  • Liposome targeting for drug delivery. HUANG, L., LEE, R. J. MORI, A., and MARUYAMA, K. Proc. Int. Symp. Controlled Release Bioact. Mater., 1995, 22, 36–37.
  • Liposomal drug delivery system. TRIVEDI, B. M., and PARIKII, R. H. East Pharm., 1993, 36 (426), 33–36.
  • Liposomes in drug targeting. BASU, M. K. Biotechnol. Genet. Eng. Rev., 1994, 12, 383–408. Topical delivery with liposomes. IMBERT, D., and WICKET-r, R. R. Cosmet. Toiletries, 1995, 110 (9), 32, 34, 37–45.
  • Microencapsulation of nanoparticles into polymer matrixes. KOMMAREDDI, N., TATA, M., JOHN, V. T., MCPHERSON, G. L., HERMAN, M. F., LEE, Y. SOOK., O'CONNOR, C. J., AKKARA, J. A., and KAPLAN, D. L. Polym. Mater. Sci. Eng., 1994, 71, 536–537.
  • Preparation of hydrophilic monodisperse microspheres by radiation precipitation polym-erization and its characteristics. KUMAKURA, M. Eur. Polym. .7., 1995, 31(11), 1095–1098.
  • Effect of isocarbacyclin methyl ester incorporated in lipid microspheres on experimental models of peripheral obstructive disease. MURAKAMI, T., SAWADA, K., TANEDA, K., HAYASHI, M., KATSUURA, Y., TANABE, H., KIYOKI, M., and ARAKI, H. Arzneimittelforschung, 1995, 45 (9), 991–994.
  • Effect of isocarbacyclin methyl ester incorporated into lipid microspheres on cutaneous blood flow in rat. SAWADA, K., TANEDA, K., KATSUURA, Y.. TANABE, H., KIYOKI, M., and ARAKI, H. Arzneimittelforschung, 1995, 45 (9), 988–990.
  • Vasorelaxant effect of isocarbacyclin methyl ester incorporated into lipid microspheres on isolated canine arteries. SAWADA, K., AOKI, K., KATSUURA, Y., TANABE, H., KIYOKI, M., and ARAKI, H. Arzneimittelforschung, 1995, 45 (9), 985–988.
  • Ex vivo anti-platelet effects of isocarbacyclin methyl ester incorporated in lipid microspheres in rabbits. INouE, K., AOKI, Y., HAYASHI, M., KITAHARA, S., TANABE, H., KIYOKI, M., and ARAKI, H. Arzneimittelforschung, 1995, 45 (9), 980–984.
  • Liposomal amphotericin B therapy of murine histoplasmosis. GRAYBILL, J. R., and BOCANEGRA, R. Antimicrob. Agents-Chemother. 1995, 39 (8), 1885–1887.
  • Immobilized liposome chromatography for analysis of interactions between lipid bilayers and peptides. ZHANG, Y., AIMOTO, S., Lu, L., YANG, Q., and LUNDAHL, P. Anal. Biochem., 1995, 229 (2), 291–298.
  • Studies on lung targeting gelatin microspheres of mitoxantrone. WANG, J. H., Lu, B., Xu, P. L., BAo, D. Y., and ZHANG, Z. R. Yao Hsueh Hsueh Pao, 1995, 30 (7), 549–555.
  • Studies on CDDP-albumin microspheres for hepatic arterial chemoembolization. ZHANG, Y. Q., JIANG, X. T., SUN, Q. R., ZHANG, G. Q., and WANG, Y. Yao Hsueh Hsueh Pao, 1995, 30(7), 543–548.
  • Photodynamic efficiency of liposome-administered tetramethyl hematoporphyrin in two human bladder cancer cell lines. BACHOR, R., REICH, E., MILLER, K., RUCK, A., and HAUTMANN, R. Urol. Res., 1995, 23 (3), 151–156.
  • Lipids—liposomes—biological membranes. BANDOROWICZ, P. J. Postepy. Biochem., 1995, 41(2), 149–150.
  • Experimental and clinical studies of degradable starch microspheres in the treatment of hepatic neoplasm: Part 1. Experimental study. YAMADA, T. Nippon Igaku Hoshasen Gakkai Zasshi, 1995, 55 (9), 663–669.
  • Studies of the organ distribution in mice of teniposide liposomes designed for treatment of diseases in the mononuclear phagocytic system. LILIEMARK, E., LILIEMARK, J., KALLBERG, N., BJORKHOLNI, M., SJOSTRONI, B., and PETERSON, C. Pediatr. Res., 1995, 38 (1), 7–10.
  • Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu. Yu, D., NIATIN, A., XIA, W., SORGI, F., HUANG, L., and HUNG, M. C. Oncogene, 1995, 11(7), 1383–1388.
  • Flagellar surface motility-gliding and microsphere movements. BLOODGOOD, R. A. Methods Cell Biol., 1995, 47, 273–279.
  • Blood urea clearance with microencapsulated urease. LEE, K. B., BOADI, D. K., and NEUFELD, R. J. J. Theor. Biol., 1995, 175 (3), 295–303.
  • Tissue preparation technique for microsphere assays of blood flow. AKYUREKLI, D. U., GERIG, L. H., and RAAPHORST, G. P. Lab. Anim. Sci., 1995, 45 (4), 415–419.
  • Microsphere formation in a series of derivatized alpha-amino acids: properties, molecular modeling, and oral delivery of salmon calcitonin. LEONE, B. A., McINNes, C., WANG, N., DENIoaiN, F., ACHAN, D., LERCARA, C., SARUBBI, D., HAAS, S., PRESS, J., BARANTSEVICH, E. et at. J. Med. Chem., 1995, 38 (21), 4257–4262.
  • Susceptibility for hydroperoxide formation of phosphatidylcholine and phosphatidylethanol-amine in liposomes. WANG, J. Y., SHIBATA, T., UEKI, T., and MIYAzAwA, T. J. Nutr. Sci. Vitaminol. (Tokyo), 1995, 41(3), 273–280.
  • Designing of thermosensitive liposomes from natural lipids for multimodality cancer therapy. CHELVI, T. P., and RALHAN, R. Int. y. Hyperthermia, 1995, 11(5), 685–695.
  • Monosize poly(ethylcyanoacrylate) microspheres: preparation and degradation properties. TUNCEL, A., CICCEK, H., HAYRAN, NI., and PICSKIN, E. J. Biomed. Mater. Res., 1995, 29 (6),721–728.
  • Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo suggesting a significant role in the immune clearance of "non-self" particles. CHONN, A., SEMPLE, S. C., and CuLus, P. R. J. Biol. Chem., 1995, 270 (43), 25845–25849.
  • Radiation pneumonitis after selective internal radiation treatment with intraarterial 90-yttrium-microspheres for inoperable hepatic tumors. LEUNG, T. W., LAD, W. Y., H. S. K., WARD, S. C., CHOW, J. H., CHAN, M. S. METREWELI, C., JOHNSON, P. J., and Li, A. K. Int. J. Radiat. Oncol. Biol. Phys., 1995, 33 (4), 919–924.
  • Immunoactivating potential of multilamellar Liposome vesicles (MLV) in murine popliteal lymph node (PLN) test. DESJARDINS, R., KRZYSTYNIAK, K., THERIEN, H. M., BANSKA, W., TANCREDE, P., and FOURNIER, M. Int. y. Immunopharmacol., 1995, 17(5), 367–374.
  • Identification of the serum factor required for liposome-primed activation of mouse peri-toneal macrophages. Modified alpha 2-macroglobulin enhances Fc gamma receptor-mediated phagocytosis of opsonized sheep red blood cells. NIuRAI, M., ARAMAKI, Y., and TsucHIYA, S. Immunology, 1995, 86 (1), 64–70.
  • Liposomal prostaglandin El in acute respiratory distress syndrome: a placebo-controlled, randomized, double-blind, multicenter clinical trial. ABRAHAM, E., PARK, Y. C., COVINGTON, P., CONRAD, S. A., and SCHWARTZ, M. Crit. Care Med., 1966, 24 (1), 10–15.
  • Preparation and evaluation of sustained release AZT-loaded microspheres: Optimization of the release characteristics using response surface methodology. ABU, I. K. A., GARCIA CONTRERAS, L., and Lux, D. R. J. Pharm. Sci., 1996, 85 (2), 144–149.
  • Thermal properties of crosslinked gelatin microspheres. AKIN, H., and HASIRCI, N. Polym. Prepr. (Am. Chem. Soc. Div. Polym. Chem.), 1995, 36 (2), 384–385.
  • Production of hollow microspheres from solid plastic granules. AKUNETS, A. A., DOROGOTOVTSEV, V. NI., MERKULIEV, Y. A., STARTSEV, S. A., and COOK, R. Fusion Technol., 28 (5), 1781-1786.
  • Growth retardation—an unexpected outcome from growth hormone and gene therapy in normal mice with microencapsulated myoblasts. AL HENDY, A., HORTELANO, G., TANNENBAUM, G. S., and CHANG, P. L. Hum. Gene. They., 1996, 7 (1), 61–70.
  • Liposome-mediated gene transfer and expression via the skin. ALEXANDER, M., Y., and AKHURST, R. J. Hum. Mol. Genet., 1995, 4 (12), 2279–2285.
  • Antimetastatic effect of immunization with liposome-encapsulated tumor cell-membrane proteins obtained from experimental tumors. ALINO, S. F., LEJARRETA, M., ALFARO, J., IRUARRIZAGA, A., BOBADILLA, NI., BLAYA, C., and CRESPO, J. immunopharmacot immunotoxico/., 1995, 17 (3), 419–436.
  • Passive targeting of anthracyclines entrapped in long-circulating (stealth) liposomes in the treatment of cancer. ALLEN, T. NI. NATO ASI Ser., 1994, Ser. A, 273, 119–128.
  • A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. ALLEN, T. M., BRANDEIS, E., HANSEN, C. B., KAO, G. Y., and Zalipsky, S. Biochim. Biophys. Acta, 1995, 1240 (2), 285.
  • Flirtations with membranes, liposomes and lipoproteins. ALLISON, A. C..7. Liposome Res., 1995, 5 (4), 641–655. 695.
  • Influence of free or liposomal amphotericin B on killing of Candida species by human peritoneal macrophages. ALLWINN, R., SCHAUMANN, R., and SHAH, P. M. Methods Find. Exp. Clin. Pharmacol., 1995, 17 (3), 163–167.
  • Antibacterial activity of liposomal amikacin against Pseud omonas aeruginosa in vitro. ANTOS, M., TRAFNY, E. A., and GRZYBOWSKI, J. Pharmacol. Res., 32 (1/2), 85–87.
  • Microencapsulation improves canine islet survival in vivo. Ao, Z., KORBUTT, G. S., WARNOCK, G. L., FLASHNER, M., COLBY, C. B., LUSKEY, K. L., and RAjorrE, R. V. Transplant. Proc., 1995, 27 (6), 3349.
  • Microencapsulation enhances canine islet survival during long-term culture. Ao, Z., KoRBurr, G. S., WARNOCK, G. L., FLASHNER, M., COLBY, C. B., and RMOTTE, R. V. Transplant Proc., 1995, 27 (6), 3350.
  • Interferon-y inductive effect of liposomes as an immunoadjuvant. ARAtvtAxt, Y SUDA, H., and TSUCHIYA, S. Vaccine, 1995, 13 (18), 1809–1814.
  • Characterization, in vitro and in vivo studies on primaquine diphosphate liposomes. ARICA, B., OZER, A. Y., ERCAN, M. T., and HINCAL, A. A. J. Microencapsul., 1995, 12 (5), 469-485. Covalent immobilization of alpha-amylase onto pHEMA microspheres: preparation and application to fixed bed reactor. ARICA, M. Y., HASIRCI, V., and ALAEDDINOGLU, N. G. Biomaterials, 1995, 16 (10), 761–768.
  • Cholate-induced disruption of calcitonin-loaded liposomes: formation of trypsin-resistant lipid-calcitonin-cholate complexes. ARIEN, A., TOOLME, H. N., and DUPUY, B. Pharm. Res., 1995, 12 (9), 1289–1292.
  • Physical stability of different liposome compositions obtained by extrusion method. ARMENGOL, X., and ESTELRICH, J. J. Microencapsul., 1995, 12 (5), 525–535.
  • The action of hydrochlorous acid on phosphatidylcholine liposomes in dependence on the content of double bonds. Stoichiometry and NMR analysis. ARNFIOLD, J., FANASENKO, 0. M., SCHILLER, J., VLADIMIROV, Y., and ARNOLD, K. Chem. Phys. Lipids, 1995, 78 (1), 55–64.
  • Liposomal muramyl tripeptide upregulates adhesion molecules on the surface of human monocytes. ASANO, T., MCINTYRE, B. W., BEDNARCZYK, J. L., WYGANT, J. N., and KLEINERMAN, E. S. Oncol. Res., 1995, 7 (5), 253–257.
  • Systemic toxicology and laser safety of laser targeted angiography with heat sensitive liposomes. ASRANI, S., D'ANNA, S., ALKAN, 0. H., WANG, W., GOODMAN, D., and ZEIMER, R. J. Ocul. Pharmacol. Ther., 1995, 11(4), 575–584.
  • Phagocytosis of monosize polystyrene-based microspheres having different size and surface properties. AYHAN, H., TUNCEL, A., BOR, N., and PicskiN, E. J. Biomater. Sci. Polyrn. Ed., 1995, 7 (4), 329–342.
  • Interaction of cationic liposomes with cells of electrically active neuronal networks in culture. AZZAZY, H. M., HONG, K., Wu, M. C., and GROSS, G. W. Brain Res., 1995, 695 (2), 231–236.
  • Influence of ionic strength on polyethylene glycol induced liposome aggregation. BABINCOVA, M. Pharntazie, 1995, 50(12), 831.
  • Synthesis and release studies of oil-containing poly(vinyl alcohol) microcapsules prepared by coacervation. BACHTSI, A. R., and KIPARISSIDES, c. y. Controlled Release, 1996, 38 (1), 49–58.
  • Liposomes modulate Kupffer cell endotoxin response. BANK EY, P., BEECHERL, E., BIBUS, D., SEE, D., and McINTYRE, K. Arch. Surg., 1995, 130 (12), 1266- t 272.
  • The transfer of antioxidants between liposomes. BARCLAY, L. R. C., MCLAUGHLIN, K. A., and VINQVIST, M. R. J. Liposome Res., 1995, 5 (4), 955–979.
  • Liposome-incorporated dexamethasone palmitate inhibits in vitro lymphocyte response to mitogen. BENAMEUR, H., LATOUR, N., SCHANDENE, L., VAN VOOREN, J. P., FLAMION, B., and LEGROS, F. J. J. Pharm. Pharmacol., 1995, 47 (10), 812–817.
  • Treatment of Kaposi's sarcoma with liposomal doxorubicin. BERGIN, C., O'LEARY, A., MCCREARY, C., SABRA, K., and MULCAHY, F. Am. J. Health Syst. Pharm., 1995, 52 (18), 2001–2004.
  • Percutaneous absorption of a new antiandrogen included in liposomes or in solution. BERNARD, E., Dusols, J. L., and WEPIERRE, J. Int. y. Pharm., 126 (1, 2), 235–243.
  • Sol gel preparation, structure and thermal stability of crystalline zirconium titanate micro-spheres. BHATTACHARYA, A. K., MALLICK, K. K., HARTRIDGE, A., and WOODHEAD, J. L..7. Mater. Sc., 31(1), 267–271.
  • Are microencapsulated antioxidants a feasible technology? BILLINGHAM, N. C., and GARCIA, T. P. Angew Makromol. Chem., 1995, 232,13–25.
  • Estimation of the H -1-/H - ratio of the reaction catalysed by the nicotinamide nucleotide transhydrogenase in chromatophores from over-expressing strains of Rhodospirillum rubrum and in liposomes inlaid with the purified bovine enzyme.BizouAaN, T., SAZANOV, L. A., AUBOURG, S., and JACKSON, J. B. Biochint. Biophys. Acta, 1996, 1273 (1), 4–12.
  • Polymeric microspheres prepared by spraying into compressed carbon dioxide. BODMEIER, R., WANG, H., DIXON, D. J., MAWSON, S., and JOHNSTON, K. P. Pharm. Res., 1995, 12 (8), 1211–1217.
  • Liposome-entrapped antimicrobial agents for abdominal infection. BOHNEN, J. M. A. Drug Targeting Delivery, 1995, 6, 135–145.
  • Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomes. BONIAN, N. L., TRON, V. A., BALLY, M. B., and CULL'S, P. R. Cancer Chemother. Pharmacol., 1996, 37 (4), 351–355.
  • TLC characterization of liposomes containing D-myo-inositol derivatives. BRAILOIU, E., HUHUREZ, G., SLATINEANtt, S., FILIPEANU, C. M., COSTULEANU, M., and BRANISTEANU, D. D. Biomed. Chromatogr., 1995, 9 (4), 175–178.
  • Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits. CABANES, A., REIG., F., ANTON, J. M., and ARBOIX, M. Am. J. Vet. Res., 1995, 56 (11), 1498–1501.
  • Adsorption of salmon calcitonin to PLGA microspheres. CALIS, S., JEYANTHI, R., TSAI, T., MEHTA, R. C., and DELucA, P. P. Pharm. Res., 1995, 12 (7), 1072–1076.
  • In vitro liposome-mediated DNA transfection of epithelial cell lines using the cationic liposome DC-CholiDOPE. CAPLEN, N. J., KINR.ADE, E., SORGI, F., GAO, X., GRUENERT, D., GEDDES, D., COUTELLE, C., HUANG, L., ALTON, E. W., and WILLIAMSON, R. Gene Ther., 1995, 2(9), 603–613.
  • Effect of liposome-albumin coatings on ferric ion retention and release from chitosan beads. CHANDY, T., and SHARMA, C. P. Biomaterials, 1996, 17(1), 61–66.
  • Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen. CHANG, A. C., and GUPTA, R. K. J. Pharm. Sci., 1996, 85 (2), 129–132.
  • Liposomal entrapment of suramin(II): interaction of suramin with phospholipids of various chain lengths. CHANG, H. C., and FLANAGAN, D. R. J. Pharm. Sci., 1995, 84 (9), 1078–1082.
  • Chromia microspheres by the sol-gel technique. CHAT-FE/HEE, M., SILADITYA, B., and GANGULI, D. Mater. Lett., 25 (5, 6), 261–263.
  • Differential effect of triiodothyronine and thyroxine on liposomes containing cholesterol: physiological speculations. CHEHIN, R. N., RINTOUL, M. R., MORERO, R. D., and FARIAS, R. N. y. Membr. Biol., 1995, 147 (2), 217–221.
  • Heat-mediated selective delivery of liposome-associated melphalan in murine melanoma. CHELVI, P. T., JAIN, S. K., and RALHAN, R. Melanoma Res., 1995, 5 (5), 321–326.
  • Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated mel-phalan in murine tumours. CHEM, T. P., JAIN, S. K., and RALHAN, R. Oncol. Res., 1995, 7 (7/8), 393–398.
  • Study of microencapsulation for pituitary transplantation: capsule preparation and in vitro study. CHEN, Z. P., BAO, Y. D., GORCZYCA, W., and MoHrt, G. Artif. Cells Blood Substit. Immobil. Biotechnol., 1995, 23 (5), 597–604.
  • A microtensiometer for the analysis of bioadhesive microspheres. CHICKERING, D. E., 3RD, HARRIS, W. P., and MATH/OWITZ, E. Biomed. Instrum. Technol., 1995, 29 (6), 501–512.
  • Oral immunization with dehydrated liposomes containing Streptococcus mutans glucosyl-transferase (GTF) in humans. CHILDERS, N. K., ZHANG, S. S., and MICHALEK, S. M. Adv. Exp. Med. Biol., 1995, 371B, 1481–1484.
  • Liposomal cyclosporine. Comparison of drug, and lipid carrier pharmacokinetics, and biodistribution. CHOICE, E., MAsIN, D., BALLY, M. B., MELOCHE, M., and MADDEN, T. D. Transplantation, 1995, 60 (9), 1006–1011.
  • Recent advances in liposomal drug-delivery systems. CrioNN, A., and Cuu-is, P. R. Curr. Opin. Biotechnol., 1995, 6 (6), 698–708.
  • Heat sterilization of archaeal liposomes. CHOQUET, C. G., PATEL, G. B., and SPacivr, G. D. Can. y. Microbiol., 1996, 42(2), 183–186.
  • Rapid diffusion of the lipid phosphorus of phosphatidylglycerol liposomes through poly. carbonate membranes is caused by the oxidation of the unsaturated fatty acids. CHOW, C. Y., and HEATH, T. D. Biochim. Biophys. Acta, 1995, 1239 (2), 168–176.
  • Microencapsulation of solid dispersions of nifedipine—A novel approach for controlling drug release. CHOWDARY, K. P. R., and RAMESH, K. V. R. N. S. Indian Drugs, 1995, 32 (10), 477–483.
  • Design and production of single-immunization vaccines using polyactide polyglycolide microsphere systems. CLELAND, J. L. Pharm. Biotechnol., 1995, 6 (Vaccine Design), 439–462.
  • Loading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradients. CLERC, S., and BARENHOLZ, Y Biochim. Biophys. Acta, 1995, 1240 (2), 257–265.
  • A comparative study of the accurate measurement of endotoxin in liposome-encapsulated hemoglobin. CLIFF, R. 0., KWASIBORSKI, V., and RUDOLPH, A. S. Artif. Clles Blood Substit. Immobil. Biotechnol., 1995, 23 (3), 331–336.
  • Successful xenografts in mice with microencapsulated rat and dog islets. COCHRUM, K., JEMTRUD, S., and DORIAN, R. Transplant-Proc., 1995, 27 (6), 3297–3301.
  • Novel liposome-based formulations for prolonged delivery of proteins and vaccines. COHEN, S., and LANGER, R..7. Liposome Res., 1995, 5 (4), 813–827.
  • Effects of liposome-entrapped platelet-activating factor in the isolated rat trachea. COSTULEANU, M., BRAILOIU, E., FILIPEANU, C. M., BALTATU, 0., SLATINEANU, S., SAILA, L., NECHIFOR, M., and BRANISTEANU, D. D. Eur.J. Pharmacol., 1995, 281 (1), 89–92.
  • Site specific microencapsulated drug targeting strategies--liver and gastrointestinal tract targeting. D'SouzA, M. J., and DE SOUZA, P. Adv. Drug Delivery Rev., 1995, 17 (3), 247–254.
  • Gene therapy for donor hearts: ex vivo liposome-mediated transfection. DALESANDRO, J., AKIMOTO, H., GORMAN, C. M., MCDONALD, T. 0., THOMAS, R., LIGGITT, H. D., and ALLEN, M. D..7. Thorac. Cardiovasc. Surg., 1996, 111 (2), 416–421. (discussion) 421–422.
  • Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice. DE HAAN, A., TOMEE, J. F., HUCHSHORN, J, P., and WILSCHGT, J. Vaccine, 1995, 13 (14), 1320–1324.
  • Liposomes in wool dyeing—stability of dye-liposome systems and their application to virgin wool fibers. DE LA MAZA, A., PARRA, J. L., MANICH, A. M., and CODERCH, L. AQEIC Bol. Tec., 1995, 46 (1), 35–42.
  • Double shell microspheres as protein carrier. DINELLA, C., LAUS, M., STAGNI, A., DORIA, M., and LANZARINI, G. Meded.—Fac. Landbouwkd. Toegepaste Biol. Wet. (Univ. Gent.), 1995,60 (4a, Forum for Applied Biotechnology, Part 1), 1999–2002.
  • Ginseng saponin liposome (GSL). DING YULING, MA, S., Lu, X., WANG, H., and AND Huo, Y. Zhongguo Yaoxue Zazhi, 1995, 30 (7), 414–417.
  • Transplantation of microencapsulated hepatocytes for liver function replacement. DIXIT, V., and GITNICK, G..7. Biomater. Sci. Polym. Ed., 1995, 7 (4), 343–357.
  • Study on transnasal aspirin-dl-lysine liposome. DoNG, Z. Zhongguo Yiyao Gongye Zazhi, 1995, 26 (5), 199–202.
  • Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B (AmBisome), granulocyte colony-stimulating factor, and surgery: report of five cases. DORNBUSCH, H. J., URBAN, C. E., PINTER, H., GINTER, G., FOTTER, R., BECKER, H., MIORINI, T., and BERGHOLD, C. Pediatr. Hematol. Oncol., 1995, 12 (6), 577–586.
  • Liposome-mediated therapy of human immunodeficiency virus type-1 and Mycobacterium infections. DUEZGUENES, N., FLASHER, D., PRETZER, E., KONOPKA, K., SLEPUSHKIN, V. A., STEFFAN, G., SALEM, I. I., REDDY, M. V., and GANGADHARAM, P. R. J. y. Liposome Res., 1995, 5 (4), 669–691.
  • Precorneal clearance of mucoadhesive microspheres from the rabbit eye. DURRANI, A. M., FARE, S. J., and KELLAWAY, I. W..7. Pharm. Pharmacol., 1995, 47 (7), 581–584.
  • Physicochemical properties of cimetidine magnetic microspheres. DUTTA, U. K., GHOSAL, S. K., and PAL, T. K. Indian Drugs, 1995, 32 (10), 484–487.
  • Radiopaque liposomes and their use in nuclear medicine. ERDOGAN, S., OEZER, A. Y., and HINCAL, A. A. FABAD Farm. Bilimler. Derg., 1995, 20 (3) 105–116.
  • The transfer of polystyrene microspheres from the gastrointestinal tract to the circulation after oral administration in the rat. EYLES, J., ALPAR, CC, FIELD, W. N., LEWIS, D. A., and KESWICK, M. y. Pharm. Pharmacol., 1995, 47 (7), 561–565.
  • Liposomal formulations of cyclosporin A: influence of lipid type and dose on pharmaco-kinetics. FAHR, A., HoLz, M., and FRICKER, G. Pharm. Re.;., 1995, 12 (8), 1189–1198.
  • The evolving role of the liposome in gene delivery. FELGNER, P. L. y. Liposome Res., 1995, 5 (4), 725–734.
  • Preparation and characterization of liposomal adriamycin. FENG, B., LANG, J., and Li, D. Zhonghua Yixue Zazhi, 1995, 75 (10), 614–661.
  • Preparation and characterization of dipalmitoylphosphatidylcholine liposomes containing interleukin-2. FLEURY, L., OLLIVON, M., DUBOIS, J. L., PulsiEux, F., and BARRATT, G. Braz. y. Med. Biol. Res., 1995, 28 (5), 519–529.
  • Reconstitution of bacteriorhodopsin and ATP synthase from Micrococcus luteus into liposomes of the purified main tetraether lipid from Thermoplasma acidophilum: proton conductance and light-driven ATP synthesis. FREISLEBEN, H. J., ZWICKER, K., JEZEK, P., JOHN, G., BETTIN, B. A., RING, K., and NAWROTH, T. Chem. Phys. Lipids, 1995, 78 (2), 137–147.
  • Preparation of macroporous microspheres with a nutshell structure by inverse polymeriza-tion of microsuspensions of poly(ethylene oxide) methacrylate macromers. FRERE, Y., DANICHER, L., and GRAMAIN, P. New Polym. Mater., 1995, 4 (4), 247–252.
  • Synthesis of short polyoxyethylene-based heterobifunctional crosslinking reagents. Applica-tion to the coupling of peptides to liposomes. FRISCH, B., BOECKLER, C., and SCHUBER, F. Bioconjugate Chem., 1996, 7 (2), 180–186.
  • Glycol methacrylate embedding of alginate-polylysine microencapsulated pancreatic islets. FRITSCHY, RITSCHY. M., GERRITS, P. 0., WOLTERS, G. H. J., PASMA, A., and SCHILFGAARDE, R. VAN. Biotech. Histochem., 1995, 70 (4), 188–193.
  • Effect of preparation conditions on size distribution and drug contents of nifedipine sustained-release microspheres. Fu, C., JIANG, X., Hu, J., and ZHANG, W. Zhongguo Yiyao Gongye Zazhi, 1995, 26 (11), 490–493.
  • SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells. FUKASAWA, M., ADACHI, H., HIROTA, K., TSUJIMOTO, M., ARAI, H., and INOUE, K. Exp. Cell. Res., 1996, 222 (1), 246–250.
  • Microencapsulated "NOVACURE" latent hardeners for one-part epoxy resin systems. VI. FUKUOKA, NI., and VANIANIURA, H. Kotingu jiho, 1995, 202, 7–13.
  • Thermosensitive sterically stabilized liposomes: formulation and in vitro studies on mechanism of doxorubicin release by bovine serum and human plasma. GABER, NI. H., HONG, K., HUANG, S. K., and PAPAHADJOPOULOS, D. Pharm. Res., 1995, 12 (10), 1407–1416.
  • Stealth liposomes and cancer targeting: a realistic compromise in drug delivery. GartizoN, A. A. J. Liposome Res. 5 (4), 705–710.
  • Cationic liposome-mediated gene transfer. GAO, X., and HUANG, L. Gene Ther., 2 (10), 710–722.
  • Potentiation of cationic liposome-mediated gene delivery by polycations. GAO, X., and HUANG, L. Biochemistry, 1996, 35 (3), 1027–1036.
  • High performance microencapsulated powders for various P/M applications. GAY, D. E. Int. J. Powder Metall (Princeton, N.J.), 32 (1), 13–25.
  • Biodegradation and tissue reaction to intravitreous biodegradable poly (D,L-lactic-co-glycolic)acid microspheres. GIORDANO, G. G., CHEVEZ, B. P., REFOJO, M. F., and GARCIA, C. A. Curr. Eye-Res., 1995, 14 (9), 761–768.
  • Optimization of microencapsulation of acrylic adhesives. GIROUD, F., PERNOT, J. M., BRUN, H., and POUYET, B. J. Microencapsul., 1995, 12 (4), 389–400.
  • Murine IgG subclass antibodies to antigens incorporated in liposomes containing lipid A. GLENN, LENN. M., RAo, NI., RICHARDS, R. L., MATYAS, G. R., and ALVING, C. R. Immunol. Lett., 1995, 47 (1-2), 73–78.
  • Liposomal presentation of antigens for human vaccines. GLucx, R. Pharm. Biotechnol., 1995, 6 (Vaccine Design), 325–345.
  • Physiological responses, organ distribution, and circulation kinetics in anesthetized rats after hypovolemic exchange tranfusion with technetium-99m-labeled liposome-encapsulated hemoglobin. GoiNs, B., KLIPPER, R., SANDERS, J. CLIFF, R. 0., RUDOLPH, A. S., and PHILLIPS, W. T. Shock, 1995, 4 (2), 121–130.
  • Liposomes as nasal drug delivery system. GOSWAMI, S., and VYAS, S. P. East Pharm., 1995, 38 (453), 33–36.
  • Microencapsulation of yeast cells and their use as a biocatalyst in organic solvents. GREEN, K. D., GILL, I. S., KHAN, J. A., and VULFSON, E. N. Biotechnol. Bioeng., 1996, 49 (5), 535–543.
  • Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine. GREENWAY, T. E., ELDRIDGE, J. H., LUDWIG, G., STAAS, J. K., SMITH, J. F., GILLEY, R. Ni., and MICHALEK, S. NI. Vaccine, 1995, 13 (15), 1411–1420.
  • Liposomes in vivo: control of behavior. GREGORIADIS, G. NATO ASI Ser., Ser. A, 1994, 273, 113–118.
  • Engineered liposomes and virosomes for delivery of macromolecules. GRIMALDI, S., GIULIANI, A., GIULIANI, A., FERRONI, L., Lisi, A., SANTORO, N., and Pozzi, D. Res. Virol., 1995, 146 (4), 289–293.
  • Efficacy of liposome encapsulated triethylenetetraamine hexaacetic acid (TTHA) against cadmium intoxication: role of lipid composition. GUPTA, S., BEHAR, J. R., SRIVASATAVA, S., MISRA, M., and SRIVASTAVA, R. C. Ind. Health, 1995, 33 (2), 83–88.
  • Preparation and release kinetics of chitosan microcapsules containing methyl violet. HA, B. J., LEE, 0. S., and LEE, Y. S. Kongop Hwahak, 1995, 6 (5), 951–958.
  • Polymer microspheres for vaccine delivery. HANES, J., CHIBA, M., and LANGER, R. Pharm. Biotechnol., 1995, 6 (Vaccine Design), 389–412.
  • Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. HANSEN, C. B., KAO, G. Y., MOASE, E. H., ZALIPSKY, S., and ALLEN, T. NI. Biochim. Biophys. Acta, 1995, 1239 (2), 133–144.
  • Receptor-mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes. HARA, T., ARAMAKI, Y., TAKADA, S., KoixE, K., and TSUCHIYA, S. Gene Ther., 1995, 2 (10), 784–788.
  • Evaluation of determination of drugs in serum by new liposome immunoassay systems. HARA, T., HIRAI, M., VAN°, A., TAMURA, K., HIGASHIHATA, NI., TATSUNII, N., FuJio, K., and MATSUURA, S. Igaku to Yakugaku, 1995, 34 (4), 767–774.
  • Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2',3'-dideoxyinosine. HARVIE, P., DESORMEAUX, A., BERGERON, M. C., TREMBLAY, M., BEAUCHAMP, D., POULIN, L., and BERGERON, M. G. Antimicrob. Agents Chemother., 1996, 40 (1), 225–229.
  • Fibrin binding of plasminogen coated liposomes in vitro. HEEREMANS, J. L. M., Los, P., PREVOST, R., CROMMELIN, D. J. A., and KLuvr, C. Thromb. Haemostasis, 1996, 75 (1), 134–139.
  • Somatostatin containing biodegradable microspheres preparared by a modified solvent evaporation method based on W/O/W-multiple emulsions. HERRMANN, J., and BODMEIER, R. Int. J. Pharm., 126 (1, 2), 129–138.
  • Interferon-y liposomes. Drug binding properties, and in vitro antiviral activity. HERRMANN, J., and STRICKER, H. Eur. J. Pharm. Biopharm., 1995, 41 (6), 361–368.
  • Poly(ethylene glycol)-lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine. HOLLAND, J. W., Hui, C., CuLus, P. R., and MADDEN, T. D. Biochemistry, 1996, 35 (8), 2618–2624.
  • Liposomal formulation of ciprofloxacin. HOPE, M. J., and Woisin, K. W. Drug Targeting Delivery, 1995, 6, 121–134.
  • Endocytosis of fluorescent microspheres by human oesophageal epithelial cells: comparison between normal and inflamed tissue. HOPWOOD, D. SPIERS, E. M., Ross, P. E., ANDERSON, J. T., McCuLLoucu, J. B., and MURRAY, F. E. Gut, 1995, 37 (5), 598–602.
  • Cell cycle-dependent cytotoxicity and induction of apoptosis by liposomal N4-hexadecy1-1-p-D-arabinofuranosylcytosine. HOBER, D. H., BALLMOOS, P. VON, SCHOTT, H., and SCHWENDENER, R. A. Br. J. Cancer, 1995, 72 (5), 1067–1073.
  • Transplantation of microencapsulated islets in rats: influence of low temperature culture before or after the encapsulation procedure on the graft function. HORCHER, A., SIEBERS, U., BRETZEL, R. G., FEDERLIN, K., and ZEKORN, T. Transplant. Proc., 1995, 27 (6), 3232–3323.
  • Effects of free and liposomized praziquantal on worm burden and antibody response in mice infected with Mesocestoides corti tetrathyridia. HRCKOVA, G., and VELEBNY, S. J. Helminthol., 1995, 69 (3), 213–221.
  • Membrane compactness affects the integrity and immunoprotection of alginate-poly-L-lysine-alkinate microcapsules. Hsu, B. R., Ho, Y. S., Fu, S. H., HUANG, Y. Y., CHiou,\ S. C., and HUANG, H. S. Transplant. Proc., 1995, 27 (6), 3227–3231.
  • Endosomolytic activity of cationic liposomes enhances the delivery of human immuno-deficiency virus-1 trans-activator protein (TAT) to mammalian cells. HUANG, L., FARHOOD, H., SERBINA, N., TEEPE, A. G., and BARSOUM, J. Biochem. Biophys. Res. Commun., 1995, 217 (3), 761–768.
  • Microsphere transport pathways in the rabbit nasal mucosa. HUANG, Y., and DONOVAN, M. D. Int. J. Pharm. Adv., 1996, 1(3), 298–309.
  • The microencapsulation of protein using a novel ternary blend based on poly(epsilon-caprolactone). HUATAN, H., CoLLErr, J. H., and Arrwoon, D. J. Microencapsul., 1995, 12 (5), 557–567.
  • The effects of polymer concentration and pore-forming agents (PVP) on HEMA-MMA micro-capsule structure and permeability. HWANG, J. R., and SEFTON, M. V. .7. Membr. Sci., 1995, 108 (3), 257–268.
  • The antibody response to a prototype liposome vaccine containing Neisseria meningitis outer membrane protein PI produced in Bacillus subtilis. IDANPAAN, H. I., MurrmaiNEN, S., WAHLSTROM, E., SAARINEN, L., LEINONEN, M., SARVAS, M., and MAKELA, P. H. Vaccine, 1995, 13 (16), 1501–1508.
  • Influence of liposomal encapsulation on the penetration of retinoic acid through human skin in vitro. IMBERT, D., KasTING, G. B., and WICKETT, R R. y. Soc. Cosmet. Chem., 1994, 45 (3), 119–134.
  • Prevention of cataract development in selenite-induced cataract in rats by instillation of liposomes containing disulfiram, and cefmetazole, Fro, Y., Kotzursai, Y., CAI, H., NEGORO, M., and Terao, M. Atarashii Ganka, 1995, 12 (11), 1755–1762.
  • Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degrada-tion of microspheres in rat muscle. JAMEELA, S. R., and JAYAKRISHNAN, A. Biomaterials, 1995, 16 (10), 769–775.
  • Liposomes, drugs and industry. JANOFF, A. S..7. Liposome Res., 1995, 5 (4), 747–749.
  • Interfacial thickness of liposomes containing poly(ethylene glycol)-cholesterol from electrophoresis. JANZEN, J., SONG, X., and BROOICS, D. E. Biophys. y., 1996, 70 (1), 313–320.
  • Omega-3 fatty acid-containing liposomes in cancer therapy. JENSKI, L. J., ZEROUGA, M., and STILLWELL, W. Proc. Soc. Exp. Biol. Med., 1995, 210 (3), 227–233.
  • The characteristics of the microencapsulated Ti-Ni alloys and their electrodes. jiAN, L., XUEPING, G., DEYING, S., YUNSHI, Z., and SHIHAI, Y. Y. Alloys Compd., 1995, 231 (1-2), 852–855.
  • Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis resporatory infection. JoNEs, D. H., MCBRIDE, B. W., THORNTON, C., O'HAGAN, D. T., ROBINSON, A., and FARRAR, G. H. Infect. Immun., 1996, 64 (2), 489–494.
  • Poly(lactide-co-glycolide) microencapsulation of vaccine antigens. Jo::Es, D., H., McBRIDE, W., and FARILAR, G. H..7. Biotechnol., 1996, 44 (1–3), 29–36.
  • Assessment of liposomal transfection of ocular tissues in vivo. JONES, S. E., McHunn, J. D., JOMARY, C., SHALIAL, A., and NEAL, M. J. Gene. Ther., 1994, 1 (Suppl. 1), S61.
  • Liposome and multiple emulsion formulations augment the anticalcifying efficacy of phosphocitrate in a cutaneous calcergy model. KANIPERMAN, H., and SALLIS, J. D. I. Pharm. Pharmacol., 1995, 47 (10), 802–807.
  • Induction of hepatitis in rats injected with HBV-DNA using HVJ-liposome. KANEDA, Y. Nippon-Rinsho, 1995, 53 (Suppl.), 104–110.
  • The use of the Rank electrode for the detection of the activity of liposomally encapsulated enzymes. KASZUBA, NI., 'TAYLOR, NI. A., and JONES, M. N. Biochem. Soc. Trans., 1995, 23 (4), 568S.
  • Enhanced in vivo performance of liposomal indomethacin derived from effervescent granule based proliposomes. KATARE, 0. P., VYAS, S. P., and Dixir, V. K. Y. Micsoencapsui., 1995, 12 (5), 487–493.
  • Targeted cancer chemotherapy with arterial microcapsule chemoembolization: review of 1013 patients. KATO, T., SATO, K., SASAKI, R., KAKINUNIA, H., and MORIYANIA, M. Cancer Chemother. Pharmacol., 1996, 37 (4), 289–296.
  • Biological and physicochemical properties of fenitrothion microcapsules as a residual spraying formulation for mosquito control. KAWADA, H., OGAWA, M., ITOH, T., and ABE, Y J. Am. Mosq. Control. Assoc., 1995, 11(4), 441–447.
  • Production of water-containing polymer microcapsules by the complex emulsion/solvent evaporation technique. Effect of process variables on the microcapsule size distribution. KENTEPOZIDOU„4., and KIPARISSIDES, C. y. Microencapsul., 1995, 12 (6), 627–638.
  • Polymerized liposomes. KHOPADE, A. J., MAHADIK, K. R., and KADANI, S. S. East Pharm., 38 (451), 21–24.
  • Lymphatic delivery and pharrnacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats. KIM, C. K. and HAN, J. H. y. Micoencapsul., 1995, 12 (4), 437–446.
  • Response to liposome-encapsulated doxorubicin (TLC D-99) in a dog with myeloma. KISSEBERTH, W. C., MACEWEN, E. G., HELFAND, S. C., VAIL, D. M., LONDON, C. L., and KELLER, E..7. Vet. Intern. Med., 1995, 9 (6), 425–8.
  • pH-Dependence of phase transition of the lipid bilayer of liposomes of stratum corneum lipids. KITAGAWA, S., YOKOCHI, N., and MUROOKA, N. Int. .7. Pharm., 1995, 126 (1, 2), 49–56.
  • Development and release behavior of impermeable PVA-wall microcapsules in cosmetics. KIYANIA, IYANIA., YANIAmo-ro, H., NAKANO, H., and KIYOMIYA, A. y. sccy, 1995, 29 (3), 258-265. Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide. KLEINERNIAN, LEINERNIAN. S. Hematol. Oncol. Clin, North Am., 1995, 9 (4), 927–938.
  • Increase of spontaneous quadrupole transition rate in the vicinity of a dielectric microsphere. Kumov, V. V., and LETOKHOV, V. S. Opt. Commun., 1996, 122 (4, 5, 6), 155–162.
  • Spontaneous transfer of viral protein from membrane of influenza virus-infected cells to liposomes is dependent on the diameter of receiver. KOGURE, K., Pro0, M., HAYASHI., and UENO, M. K. Biol. Pharm. Bull., 1995, 18 (8), 1168–1170.
  • Physocochemical aspects of the preparation and properties of poly(L-lysine-alt-terephthalic acid) microcapsules: a review. KONDO, T. Malays. y. Sci., Ser B, 1994, 16 (1 & 2), 1–5.
  • Successful reversal of diabetes in nude mice by transplantation of microencapsulated porcine neonatal islet cell aggregates. Koaaurr, G. S., Ao, Z., WARNOCK, G. L., FLASHNER, M., and RAJorre, R. V. Transplant. Proc., 1995, 27 (6), 3212.
  • Rapid high-yield purification and liposome reconstitution of polyhistidine-tagged sensory rhodopsin I. KREBS, M. P., SPUDICH, E. N., and SPUDICH, J. L. Protein Expression Purif., 6 (6), 780–788.
  • Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation. KRUGER, W., STOCKSCHLADER, RUSSNIANN, B., BERGER, C., HOFFKNECHT, M., SOBOTTKA, I., KOHLSCHUTTER, B., KROSCHKE, G., KROGER, N., HoasTmANN, M., et al. Br. y. Haematol., 1995, 91(3), 684-690. Pharmacodynamics of liposomes. KUMAR, S., KHAR, R. K., SHARMA, S. N., and CHAUHAN, U. P. S. East Pharm., 1995, 38(445), 39–43.
  • Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine for long-acting therapy of viral retinitis. KUPPERMANN, B. D., Assn., K. K., VUONG, C., BESEN, G., WILEY, C. A., DE CLERCQ, E., BEaceaoN, L. G., CONNOR, J. D., PURSLEY, M., MUNGUIA, D., and FREEMAN, W. R. y. Infect. Dis., 1996, 173 (1), 18–23.
  • Cardiac function of an acute ischemic heart failure model produced by microsphere injection into the left coronary artery. Pressure-volume relationship as determined by a conductance catheter. KURODA, H., and SUGA, H. ASAIO 1., 1995, 41(4), 855-862. Cytokine-containing liposomes as adjuvants for HIV subunit vaccines. LACHMAN, L. B., L. C., RAO, X. NI., Hu, X., BUCANA, C. D., ULLRICH, S. S., and CLELAND, J. L. AIDS Res. Hum. Retroviruses, 1995, 11(8), 921–932.
  • Cytokine-containing liposomes as adjuvants for subunit vaccines. LACHMAN, L. B., SHIH, L. C. N., RAO, X. NI., ULLRICH, S. E., and CLELAND, J. L. Pharm. Biotechnol., 1995, 6 (Vaccine Design), 659–671.
  • Transplantation of porcine and bovine islets into mice without immunosuppression using uncoated alginate microspheres. LANZA, R. P., KUHTF EIBER, W. NI., ECKER, D. M., MARSH, J. P., and CHICK, W. L. Transplant Proc., 1995, 27 (6), 3321.
  • Physicochemical, pharmacokinetic and pharmacodynamic evaluation of liposomal tacro-limus (FK 506) in rats. LEE, M. J., STRAUBINGER, R. NI., and Jusxo, W. J. Pharm. Res., 1995, 12 (7), 1055–1059.
  • Alkali cation transport through liposomes by the antimicrobial fusafungine and its con-stitutive enniatins. LEVY, D., BLUZAT, A., SEIGNEURET, NI., and KIGAUD, J. L. Biochem. Pharmacol., 1995, 50 (12), 2105–2107.
  • Kinetic and thermodynamic modeling of the formation of polymeric microspheres using solvent extraction/evaporation method. Li, W. I., ANDERSON, K. W., DELucA, P. P. J. Controlled Release, 1995, 37 (3), 187–198.
  • Prediction of solvent removal profile and effect on properties for peptide-loaded PLGA microspheres prepared by solvent extraction/evaporation method. Li, W. I., ANDERSON, K. W., MEHTA, R. C., and DELucA, P. P. J. Controlled Release., 1995, 37 (3), 199–214.
  • Surface modification of phospholipid liposomes by incorporation of glycolipid. Li, Z. C., HE, W., and Li, F. NI. Chin. Chem. Lett., 1995, 6 (11), 947–950.
  • Interactions of Ca2+ with phospholipid liposomes containing 13-eleostearic acid. Li, Z., HE, W., and Li, F. Shengrou Wuli Xuebao, 1995, 11(3), 362–36.6
  • Liposome-encapsulated silver sulfadiazine (SSD) for the topical treatment of infected burns: thermodynamics of drug encapsulation and kinetics of drug release. LICHTENSTEIN, A., and MARGALIT, R. J. Inorg. Biochem., 1995, 60 (3), 187–198.
  • Targeting of teniposide to the mononuclear phagocytic system (MPS) by incorporation in liposomes and submicron lipid particles; an autoradiographic study in mice. LILIEMARK, E., SJOSTROM, B., LILEMARK, J., PETERSON, C., KALLBERG, N., and LARSSON, B. S. Leuk. Lymphoma, 1995, 18 (1-2), 113–118.
  • Development of local drug delivery system: prolonged sciatic nerve blockade from bio-degradable microspheres. List. J. Yakche Hakhoechi, 1995, 25 (3, Suppl.), S33–S35.
  • Liposome clearance from blood: different animal species have different mechanisms. Liu, D., Hu, Q., and SONG, Y. K. Biochem. Biophys. Acta, 1995, 1240 (2), 277–284.
  • Antibody dependent, complement mediated liver uptake of liposomes containing GMl. D., SONG, Y., and Liu, F. Pharm. Res., 1995, 12 (11), 1775–1780.
  • Lung annexin II promotes fusion of isolated lamellar bodies with liposomes. Liu, L., FISHER, A. B., and ZIMMERMAN, U. J. Biochim. Biophys. Acta, 1996, 1259 (2), 166–172.
  • Accumulation of protein-coated liposomes in an extravascular site: influence of increasing carrier circulation lifetimes. LONGMAN, S. A., TARDI, P. G., PARR, M. J., CHOI, L., CULLIS, P. R., and BALLY, NI. B. y. Pharmacol. Exp. Ther., 1995, 275 (3), 1177–1184.
  • A model approach for assessing liposome targeting in vivo. LONGMAN, S. A., CuLus, P. R., BALLY, NI. B. Drug Delivery, 1995, 2 (3/4), 156–165.
  • Botulinum toxin type A inhibits Ca2+-dependent transport of acetylcholine in reconstituted giant liposomes made from presynaptic membranes from cholinergic nerve terminals. LOPEZ, A. E., CANAVES, J., ARRtsAs, M., CASANOVA, A., MARSAL, J., GONZALEZ, R. J. NI., and SOLSONA, C. Neurosci. Lett., 1995, 196 (1-2), 37–40.
  • Preparation and dissolution pattern of Eudragit microcapsules containing theophylline sodium glycinate. Lu, J., Liu, C., JiAo, Z., and XIAO, B. Zhongguo Yiyao Gongye Zazhi, 1995, 26 (10), 443–446.
  • Concentration dependence of liposomes-water partition coefficient of hydroxyphenyl fatty acid derivatives. LURIE, E. Y., KAPLUN, A. P., VASILENKO, I. A., DUBOVSKI, P. V., and SHVETS, V. I. Biol. Membr., 12 (5), 546–552.
  • Microencapsulation of 0/VV emulsions by formation of a protein-surfactant insoluble complex. MAGDASSI, S., and VINETSKY, Y. J. Microencapsul., 1995, 12 (5), 537–545.
  • Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. MAHATO, R. I., KAWABATA, K., NOMURA, T., TAKAKURA, Y., and HASHIDA, M. J. Pharm. Sci., 1995, 84(11), 1267–1271.
  • In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes. MAHATO, R. I., KAWABATA, K., TAKAKURA, Y., and HASHIDA, M. J. Drug. Target., 1995, 3 (2), 149–157.
  • Effects of orally administered Liposomes with soybean-derived sterols and their glucosides on rat body weight. MAITAN: Y., HAZAMA, M., TOJO, H., Q1, X. R., and NAGAI, T. Biol. Pharm. Bull., 18 (11), 1551-1555.
  • pH and ionic strength-sensitive drug release from poly(L-lysine-alt-terephthalic acid) micro-capsules. Effects of dissociable groups on the microcapsule structure. MAK:No, K. Asahi Garasu Zaidan losei Kenkyu Seika Hokoku, 1995, 245–250.
  • The effect of free gallium and gallium in liposomes on cytokine and nitric oxide secretion from macrophage-like cells in vitro. MAKKONEN, N., HIRVONEN, M. R., SAVOLAINEN, K., LAPINJOKI, S., and MOENKKOENEN, J. Inflammation Res., 44(12), 523–528.
  • Liposome-mediated drug targeting in topical and regional therapies. MARGALIT, R. Crit. Rev. Ther. Drug Carrier Syst., 1995, 12(2 & 3), 233–261.
  • Cocaine hydrochloride in poly(L-lactide) microspheres potentiates effects on the locomotion of rats. MASINDE, L. E., BERTELSEN, G. A., SCHLEMMER, R. F. JR., GILATI, A., and HICKEY, A. J. Methods Find. Exp. Clin. Pharmacol., 1995, 17 (9), 597–600.
  • Effect of electric fields on cluster formation of egg phosphatidylcholine liposomes in flocculation region by Ca2+ ions. MATSUMURA, H. Colloids Surf., A, 104 (2/3), 343–351.
  • Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques. NIAyEa, L. D., and ST ONCE, G. Anal. Biochem., 1995, 232 (2), 149–157.
  • Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy. :MCLACHLAN, G., DAVIDSON, D. J., STEVENSON, B. J., DICKINSON, P., DAVIDSON SMITH, H., DORIN, J. R., and PORTEOUS, D. J., Gene Ther., 1995, 2 (9), 614–622.
  • Liposome-based studies of human neutrophil degranulation and protein-lipid interactions in membrane fusion. MEERS, P.7. Liposome Res., 1995, 5 (4), 761–787.
  • Brain tissue reaction following intracerebral injection or free of liposomally encapsulated BSH. MEHTA, S. C., OLSON, J. J., and Lu, D. R. Drug Delivery, 1995, 2 (3/4), 175–180.
  • Influence of the level of lipid peroxidation and the pH value of liposomal suspension on its antibacterial activity. MELYANTSEVA, L. P., KREINES, V. NI., and BULGAKOV, V. G. Zh Mikrobiol, Epidemiol. Immunobiol., 1995 (1), 6–10.
  • Liposomes in cosmetics. II. Entrapment of a hydrophillic probe. MENIOLI, A., PALERMM, L. G., TRAVAGLI, V., and ALFIAIQUE, F..7. Soc. Cosmet. Chem., 1994, 45 (3), 167–172.
  • Modulation of daunorubicin intracellular accumulation in P-glycoprotein expressing MCF-7 human breast adenocarcinoma cells by thermosensitive-liposome encapsulation and hyperthermia. MERLIN, J. L., MARCHAL, S., RAMACCI, C., NOTTER, D., and VIGNERox, C. Int. .7. Hyperthermia, 1995, 11(6), 855–865.
  • Drug effects on intraocular pressure and vascular flow in the bovine perfused eye using radiolabelled microspheres. MILLAR, J. C., WILSON, W. S., CARR, R. D., and HUMPHRIES, R. G. y. Ocul. Pharmacol. Ther., 1995, 11(1), 11–23.
  • X-ray diffraction analysis of cytochrome P450 2B4 reconstituted into liposomes. MILLER, J. P., HERBET-re, L. G., and WHITE, R. E. Biochemistry, 1996, 35 (5), 1466–1474.
  • Introduction of murine 11-4 gene into B16(F10) melanoma tumors by direct gene transfer with DNA-liposome complexes. NIissoL. E., SOCHANIK, A., and SZALA, S. Cancer Lett., 1995, 97 (2), 189–193.
  • Efficient gene transfer into mammalian cells using fusogenic liposome. MIZUGUCHI, H., NAKAGAWA, T., NAKANISHI, M., IMAZU, S., NAKAGAWA, S., and NIAvumi, T. Biochem. Biophys. Res., Commun., 1996, 218 (1), 402–407.
  • The significance of membrane lipids in exocytosis: control of liposome-evoked amylase release from secretory granules isolated from the rat parotid gland. MizuNo, K. M., INOKUCHI, H., KAMEYAMA, Y., YASHIRO, K., SHIN, S. 0., and FUJITA, A.3'. Biochem. (Tokyo), 1995, 118 (4), 693–699.
  • Alpha-tocopherol encapsulated in liposomes. MOJOVIC, L., SILER, M. S., ZAHARIJEV, J., and BUGARSKI, B. Hem. Ind., 49 (10), 420–423.
  • EPR study of spermine interaction with multilamellar phosphatidylcholine liposomes.1VIomo, F., WISNIEWSKA, A., and STEVANATO, R. Biochim. Biophys. Acta, 1995, 1240 (1), 89–94.
  • Fast solute release from photosensitive liposomes: an alternative to 'caged' reagents for use in biological systems. MoKGAN, C. G., BISBY, R. H., JOHNSON, S. A., and MITCHELL, A. C. FEBS Lett., 1995, 375 (1-2), 113–116.
  • Liposome-entrapped phenytoin locally suppresses amygdaloid epileptogenic focus created by db-cAMP/EDTA in rats. MORI, N., KUROKOUCHI, A., OSONOE, K., SAITOH, H., ARICA, K., Suzuxi, K., and IWATA, Y. Brain Res., 703 (1, 2), 184–190.
  • Cis/trans isomerization in azobenzene-chain liposomes. Moss, R. A., and JIANG, W. Langmuir, 1995, 11(11), 4217–4221.
  • Novel magnetic microspheres on the basis of poly(vinyl alcohol) as affinity medium for quantitative detection of glycated haemoglobin. 'MULLER, S. D., and BRUNNER, H. J. Chromatogr. A., 1995, 711 (1), 53–60.
  • Lipid dependent cardio-hemodynamic tolerability of liposomes in rats. Muscrucx, P., SACHSE, A., LEIKE, J., WEHRMANN, D., and KRAUSE, W. J. Liposome Res., 1995, 5 (4), 933–953.
  • Is control of distribution of liposomes between tumors and bone marrow possible? NAGAYASU, A., UCHIYAMA, K., NISHIDA, T., YAMAGIWA, Y KAWAI, Y., and KIWADA, H. Biochim. Biophys. Acta, 1996, 1278 (1), 29–34.
  • Reconstitution of purified P-glycoprotein into liposomes. NAITO, M., and TSURUO, T. J. Cancer Res. Clin. Oncol., 121 (9/10), 582–586.
  • Heat-sensitive inorganic microcapsules. NAICAHARA, Y., and TANAKA, Y. Koatsu Gasu, 1995, 32 (12), 984–990.
  • Fusogenic liposomes: a new system for gene transfer. NAKANISHI, M., Tanpakushitsu Kakusan Koso, 1995, 40 (17), 2550–2555.
  • Fusogenic liposome-mediated gene transfer. NAICANISHI, M., and MIZUGUCHI, H. Igaku no Ayumi, 1995, 175 (9), 631–634.
  • Antimicrobial effect of lipin, a liposomal drug. NASR, A. N Mikrobiol. Zh., 1993, 55 (6), 62–65.
  • Influence of liposomes rich in unsaturated or saturated fatty acids on the growth of human xenotransplanted mammary carcinomas and on the levels of heart type fatty acid binding protein. NAUNDORF, H., ZSCHIESCHE, W., RESZICA, R., and FICHTNER, I. In Vivo, 1995, 9 (3), 247–251.
  • Influence of nonionic liposomal composition on topical delivery of peptide drugs into pilosebaceous units: an in vivo study using the hamster ear model. NIEMIEC, S. M., RAMACHANDRAN, C., and WEINER, N. Pharm. Res., 1995, 12 (8), 1184–1181.
  • A novel drug delivery system for treatment of hormone dependent diseases. Leuplin. Monthly microcapsule-depot form of leuprorelin. OGAWA, Y. Kagaku to Kogyo (Tokyo), 1995, 48 (11), 1361-1363_
  • Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. ON, Y. K., Nix, D E., STRAUBINGER, R. M. Antimicrob. Agents Chemother., 1995, 39 (9), 2104–2111.
  • A study on accuracy of rCBF measurements using the conventional microsphere method with N-isopropyl-p-(123-1)iodoamphetamine and SPECT. OHKUBO, M., ODANO, I., TAICAFIASHI, N., TAKAHASHI, M., OHTAKI, H., NOGUCHI, E., KASAHA RA, T., HATANO, M., and YOKOI, T. Kaku-Igaku, 1995, 32 (12), 1323–1331.
  • Gene therapy of brain tumor with DNA/liposome. OHTA, S., and YOSHIIDA, J. Igaku no Ayumi, 1995, 175 (9), 701–740.
  • Biodegradable microspheres in drug delivery. OKADA, H., and TOGUCHI, H. Crit. Rev. Ther. Drug Carrier Syst., 1995, 12 (1), 1–99.
  • Permeability change of liposomal membrane induced by interleukin-1 alpha. Oxu, N., SAITO, N., OKADA, S., WATANABE, N., and KOBAYASHI, Y. y. Biochem. (Tokyo), 1995, 118 (4), 832–835.
  • Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum. OLIVA, G., GRADONI, L., CIARAMELLA, P., DE LUNA, R., CORTESE, L., ORSINI, S., DAVIDSON, R. N., and PERSECHINO, A. J. Antimicrob. Chemother., 36 (6), 1013-1019.
  • Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free fos-carnet. OMAR, R. F., DUSSERRE, N., DESORMEAUX, A., PouuN, L., TREMBLAY, M., BEAUCHAMP, D., and BERGERON, M. G. Antimicrob. Agents Chemother., 1995, 39 (9), 1973–1978.
  • Poly(methacrylic acid)-induced liposome aggregation for measuring drug entrapment. OTO, E. K., ZALIPSKY, S., QUINN, Y. P., Zilu, G. Z., and USTER, P. S. Anal. Biochem., 1995, 229 (1), 106–111.
  • A new oral microsphere drug delivery system. OTTENBRITE, R. M., ZHAO, R., and MILSTEIN, S. Macromol. Symp., 101 (5th International Polymer Conference Challenges in Polymer Science and Technology, 1994), 1996, 379–387.
  • Liposomal cyclosporine. Characterization of drug incorporation, and interbilayer exchange. OUYANG, C., CHOICE, E., HOLLAND, J., MELOCHE, M., and MADDEN, T. D. Transplantation, 1995, 60 (9), 999–1006.
  • Efficacy of sustained-release ciprofloxacin microspheres against device-associated Pseudo-monas aeruginosa biofilm infection in a rabbit peritoneal model. Owusu, A. G., ROGERS, J. A., MORCK, D. W., and OLSON, M. E. 5. Med. Microbial., 1995, 43 (5), 368–376.
  • Interaction of hypochlorite with hydroperoxides and other oxidation products of phospha-tidylcholine liposomes. PANASENKO, 0. NI., ARNHOLD, J., VLADIMIROV, I., and SERGIENKO, V. 1. Biokhimiia, 1995, 60 (9), 1419–1428.
  • Chronokinetics of liposomal encapsulated ampicillin in fasting and nonfasting rats. PARDUE, R., and WHITE, C. A. /. Pharm. Sc., 1996, 85 (3), 309–312.
  • The rat epididymal fat pad as an implantation site for the study of microcapsule bio-compatibility: validation of the method. PARISEAU, J. F., LEBLOND, F. A., HAREL, F., LEPAGE, Y., and HALLE, J. P.5. Biomed. Mater. Res., 1995, 29 (11), 1331–1335.
  • Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. PARK, T. G. Biomaterials, 1995, 16 (15), 1123–1130.
  • Pharmacodynamics of a liposomal preparations for local anesthesia. PETERS, and H., Mou.., F., Arzneim-Forsch, 1995, 45 (12), 1253–1256.
  • Modulation of murine macrophage nitric oxide synthesis by liposomal phospholipids: correlation with liposome immune adjuvant activity. PHILLIPS, N. C., and GAGNE, L. 5. Drug Target, 1995, 3 (2), 137–147.
  • Liposome design and vaccine development. PIETROBON, P. J. F. Pharm. Biotechnol., 1995, 6 (Vaccine Design), 347–361.
  • Dithiocarbamate-incorporated monodisperse polystyrene microspheres as specific sorbents: adsorption of cadmium ions. PISKIN, E., KESENCi, K., SATIROGLU, N., and GENC, 0.5. Appl. Polym. Sc,, 1996, 59 (1), 109–117.
  • The effect of different liposomal formulations on the interaction of Zn(II)-phthalocyanine with isolated low and high density lipoproteins. Pow, L., BIANCO, G., REDO, E., and Join, G. Int. 5. Biochem. Cell Biol., 1995, 27 (12), 1249–1255.
  • In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant. POWERS, D. C., HANSCOME, P. J., and PIETROBON, P. J. Vaccine, 1995, 13 (14), 1330–1335.
  • Liposomal incorporation changes the effect of 1,25-dihydroxyvitamin D3 on the phospho-lipase C signal transduction pathway and the eicosanoid cascade on keratinocytes in vitro. PRUEFER, K., and JIRIKOWSKI, G. F. Biochem. Pharmacol., 1996, 51(3), 247–252.
  • Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema. PURCELL, F., and CORRIS, P. A. Thorax, 1995, 50 (12), 1321–1323.
  • Relation of rigidity of membrane and stability of dipalmitoylphosphatidylcholine liposomes with soybean-derived sterols prepared by reversed-phase evaporation vesicle method. Q1, X. R., MAITANI, Y., and NAGAI, T. Chem. Pharm. Bull., 44 (1), 237–240.
  • Liposome-encapsulated hemoglobin: interactions with the mononuclear phagocytic system. RARINOVICI, R., NEVILLE, L., FEUERSTEIN, G., and RUDOLPFI, A. S. Drug Targeting Delivery, 1995, 6, 227–239.
  • Cryopreservation of microencapsulated canine islets. RAjorre, R. V., Au, Z., Kortaurr, G. S., LAKEY, J. R., FLASHNER, M., Court, C. B., and WARNOCK, G. L. Transplant. Proc., 1995, 27 (6), 3389.
  • Depletion of thymic macrophage in the rat by liposome-encapsulated dichloromethylene diphosphonate. REzzAxi, R., RODELLA, L., and VENTURA, R. G. Arch. Histol. Cytol., 1995, 58 (4), 427–433.
  • Temperature-induced changes in fluoroescence properties as a probe of porphyrin micro. environment in lipid membranes. 1. The partition of hematoporphyrin and proto-porphyrin in Liposomes. RICCHELLI, F., GOBBO, S., JORI, G., MoRENo., and SALET, C. EU,' . 5. Biochem., 1993, 233 (1), 159–164.
  • Preparation and characterization of indomethacin-loaded microspheres. RicHey, T., and HARRIS, F. W. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1995, 36 (2), 255–256.
  • Dopamine secretion by PC12 cells microencapsulated in a hydroxyethyl methacrylate-methyl methacrylate copolymer. ROBERTS, T., DE BONI, U., and SEFTON, NI. V. Bio-materials, 1996, 17 (3), 267–275.
  • Comparative evaluation of acute cerebral vasospasm by the microsphere and the angio-graphy techniques. Roux, S., CLOZEL, M., WOLFGANG, R., SPRECHER, U., and CLOZEL, J. P. 5. Neurosci. Methods, 1995, 59 (2), 245–252.
  • Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitro-gen-containing oxidized lipid derivatives. RUBBO, H., PARTHASARATHY, S., BARNES, S., KIRK, M., KALYANARAMAN, B., and FREEMAN, B. A. Arch. Biochem. Biophys., 1995, 324 (1), 15–25.
  • Administration of liposome-encapsulated hemoglobin as a red cell substitute: safety and efficacy of an artificial oxygen carrying fluid. RUDOLPH„k. S. Drug Targeting Delivery, 1995, 6, 217–225.
  • Enzyme replacement therapy in ENU2 phenylketonuric mice using oral microencapsulated phenylalanine ammonia-lyase: a preliminary report. SAFOS, S., and CHANG, T. NI. Art if Cells Blood Substit. Immobil. Biotechnol., 1995, 23 (6), 681–692.
  • Effects of 1-1+ liberated from hydrolytic cleavage of polyster microcapsules on their perm-ability and degradability. SAH, H., and CHIEN, Y. W. 5. Pharm. Sci., 1995, 84 (11), 1353–1359.
  • Preparation of ranitidine hydrochloride microcapsules and its biphasic relase kinetics. SAHA, N., and PAL, T. K. Drug Delivery, 1995, 2 (3/4), 215–220.
  • Effect of lipid ozonation products on liposomal membranes detected by Laurdan fluor-escence. SALGO, NI. G., CUETO, R., and PRYOR, W. A. Free Radic. Biol. Med., 1995, 19 (5), 609–616.
  • Eradication of interieukin 5-transfected j558L plasmacytomas in mice by hydrogen peroxide- generating Stealth liposomes. SAMOSZUK, M. K., WIMLEY, W. C., and NGUYEN, V. Cancer Res., 1996, 56 (1), 87–90.
  • Interaction of cationic liposomes with skin bacteria. SANDERSON, N. M., and JONES, M. N. Biochem. Soc. Trans., 23 (4), 561S.
  • The application of liposomes to antiviral therapy: passive immunity and immunomodulation. SARAVOLAC, E. G., and WONG, J. P. Drug Targeting DeKvery, 1995, 6, 51–67.
  • Syntheses of novel galactosyl ligands for liposomes and the influence of the spacer on accumulation in the rat liver. SASAKI, A., MURAHASHI, N., YAMADA, H., and IVIoRixAwA, A. Biol. Pharm. Bull, 1995, 18 (5), 740–746.
  • Intraduodenal immunization with microencapsulated CFA/II induces a delayed, anti-CFA/IL IgC antibody-secreting spleen cell response. SAU, K., REID, R. H., MCQUEEN, C., BOEDEKER, E. C., NELLORE, R., DALAL, P., and BHAGAT, H. R. Adv. Exp. Med. Biol., 1995, 371B, 1469–1474.
  • Efficiency of in vivo gene transfection into transplanted rat heart by coronary infusion of HVJ liposome. SAWA, Y., SUZUKI, K., BAI, H. Z., SHIRAKURA, R., MORISHITA, R., KANEDA, Y., and MATSUDA, H. Circulation, Suppl., 1995, 92 (9), 479–482.
  • In vivo uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. SCHMIDT, E. U., HASAN, T., SCHOMACKER, K., FLOTTE, T., and BIRNGRUBER, R. Lasers Stag. Med., 1995, 17 (2), 178–188.
  • Pharmacokinetics of iopromide liposomes in rabbits. SCHUHMANN, G. G., LEIKE, L., SACHSE, A., and KRAUSE, W. Pharm. Res., 1995, 12 (7), 1065–1071.
  • A phase II trial of doxorubicin HC1 Liposome Injection in patients with advanced pancreatic adenocarcinoma. SCHWARTZ, G. K., and CASPER, E. S. Invest. New Drugs, 1995, 13 (I), 77–82.
  • Oral antitumour activity in murine L1210 leukaemia and pharmacological properties of liposome formulations of N4-alkyl derivatives of 1-beta-D-arabinoforanosylcytosine. SCHWENDENER, R. A., HOMIER, D. H., ODERMATT, B., and SCHOTT, H. J. cancer Res. Chu, Oncol., 1996, 122 (2), 102–108.
  • Embryotoxicity of free and liposome encapsulated taxol in the chick. SciALLI, A. R., DEScsso, J. M., RAHMAN, A., HUSAIN, S. R., and GOERINGER, G. C. Pharmacology, 1995, 51 (3), 145–151.
  • Measurement of airway mucosal blood flow with dimethylether: validation with micro-spheres. SCURI, M., MCCASKILL, V., CHEDIAK, A. D., ABRAHAM, W. M., and WANNER, A. J. Appl. Physiol., 1995, 79 (4), 1386–1390.
  • Influence of cholesterol on the association of plasma proteins with liposomes. SEMPLE, S. C., CHONN, A., and CuLms, P. R. Biochemistry, 1996, 35 (8), 2521–2525.
  • A novel strategy affords high-yield coupling of antibody Fab' fragments to liposomes. SHAHINIAN, S., and SILVIUS, J. R. Biochim. Biophys. Acta, 1995, 1239 (2), 157–167.
  • Microcapsules obtained from complex coacervation of collagen and chondroitin sulfate. SHAO, W., and LEONG, K. W. y. Biomater, Sci., Polym. Ed., 1995, 7 (5), 389–399.
  • Preparation and poly(lactic acid) microspheres containing 5-fluorouracil and tests of drug release. SHEN. Z., ZHU, J., Wu, L., XIAO, Y., CHENG, J., Wu, Z., and Li, S. Zhongguo Yiyao Gongye Zazhi, 1995, 26 (7), 306–309.
  • Influence of steric stabilization of liposome-encapsulated hemoglobin on Listeria mono-cytogenes host defense. SHERWOOD, R. L., McCoamic):, D. L., ZHENG, S., and BEISSINGER, R. L. Artif. Cells Blood Substit. Immobil. Biotechnol., 1995, 23 (6), 665–679.
  • Interaction of partially unfolded forms of Torpedo acetylcholinesterase with liposomes. SHIN, 1., SILMAN, I., WEINER, L. M. Protein Sci., 1996, 5 (1), 42–51.
  • Application of liposome immune lysis assay for studies on antiganglioside antibodies. SHIRATORI, M., ITO, K., KAWAI, K., YASUDA, T., NAOI, M., and TAKAHASHI, A. J. cun. Biochent. Nutr., 19 (1), 45–54.
  • Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy. SIEGAL, T., HOROWITZ, A., and GABIZON, A. y. Neurosurg, 1995, 83 (6), 1029–1037.
  • Controlled polymerization of c-caprolactone—from macromolecules to microspheres. SLOMKOWSKI, S. Macromol. Symp., 1996, 103 (Polymers and Medicine), 213–228.
  • Interleukin-2 lipid microspheres. II. In vitro and in vivo assessment of a colloidal drug carrier containing interleukin-2. SORENSON, M. A., ZEBEDE, M., ANDERSON, P. M., and RAHMAN, Y. E. Drug Delivery, 1995, 2 (3/4), 207–214.
  • Interleukin-2 lipid microspheres. I. Development and evaluation of the colloidal drug carrier. SORENSON, L., M. ZEBEDE, M., ANDERSON, P., and RAHMAN, Y. E. Drug Delivery, 1995, 2 (3/4), 198–206.
  • Lipid oxidation in bilayer liposomes induced by radicals from the surrounding water phases. SPRINZ, H., and BREDE, 0., Radiat. Phys. Chem., 1996, 47 (3), 511–513.
  • Brownian motion at liquid-gas interfaces. 4. Experiments with glass microspheres in the presence of surfactants. STARCHEV, K., AVRAMOV, M., and RADOEV, B. Langnzuir, 1995, 11 (7), 2848.
  • Liposomal drug delivery: possibilities for manipulation. S-roam, G., BARKER, W. 1. A. J. M., WOODLE, M. C., BLUME, G., NASSANDER, U. K., VINGERHOEDS, M. H., HAISNIA, H., and CRONINIELIN, D. J. A. NATO ASI Ser., Ser A, 1994, 273, 129–138.
  • Evaluation of an aliphatic polyurethane as a microsphere matrix for sustained theophylline delivery. SUBHAGA, C. S., Ravi, K. G., SUNNY, M. C., and JAYAKRISHNAN, A. y. Microencapsul., 1993, 12 (6), 617–625.
  • Study on lyophilized arabinoside liposomes. Sc,, Y., LIUNI B., and XIA, D. Zhongguo Tiyuan Yaoxue Zazhi, 1995, 15(11), 487–490.
  • Microencapsulation of lobster carotenoids within poly(vinyl alcohol) and poly(D, L-lactic acid) membranes. SUN, Z. NI., PONCELET, D., CONWAY, J., and NEUFELD, R. J. j. Micro-encapsul., 1995, 12 (5), 495–504.
  • Complement activation by liposome-encapsulated hemoglobin in vitro: the role of endotoxin contamination. SZEBENI, J., WAssee, N. NI., RUDOLPH, A. S., and ALVING, C. R. Artif. Cells Blood Substit. Immobil. Biotechnol., 1995, 23 (3), 355–633.
  • Assessment of coronary vasodilator reserve by N-13 ammonia PET using the microspheres method and Patlak plot analysis. TADANIURA, E., TAMAKI, N., YONEKURA, Y., KIJDOH, T., MAGATA, Y., TORIZUKA, T., TATENO, NI., NOHARA, R., SASAYANIA, S., and KONISHI, J. Ann. Nucl. Med., 1995, 9 (3), 109–118.
  • Benzoyl peroxide microcapsules I. Preparation of core material. TATAPUDY, H., and MADAN, P. L. Indian Drugs, 1995, 32(6), 239–248.
  • The effect of different dose levels of degradable starch microspheres (Spherex) on the distribution of a cytotoxic drug after regional administration to tumor-bearing rats. 'FEDER, H., JOHANSSON, C. J., D'ARGY, R., LUNDIN, N., and GUNNARSSON, P. 0. Eur. y. Cancer, Part A, 1995, 31A (10), 1701–1705.
  • Enhancement of nonspecific resistance by liposome-encapsulated immunomodulators does not affect skin graft rejection in mice. TEN HAGEN, T. L., VOSSEN, A. C., VAN VIANEN, W., 'FIBRE, 0. J., SAVELKOUL, H. F., HEREMANS, H., and BANKER, W. I. A. Transplantation, 1995, 60 (11), 1211–1214.
  • Prophylactic and therapeutic effects of liposome entrapped carboplatin for metastatic liver cancer. Study of intraportal administration. TERADA, J. Nagoya-shiritsu Daigaku Igakkai Zasshi, 1995, 46 (4), 459–67.
  • Synergistic interactions between vitamin A and vitamin E against lipid peroxidation in phosphatidylcholine liposomes. TESORIERE, L., BONGIORNO, A., PINTAUDI, A. NI., D'ANNA, R., DARPA, D., and LIVREA, NI. A. Arch. Biochem. Biophys., 1996, 326 (1), 57–63.
  • Biodegradable indium-111 labeled microspheres for in vivo evaluation of distribution and elimination. THAN00, B. C., DOLL, W. J., MEHTA, R. C., DIGENIS, G. A., and DELucA, P. P. Pharm. Res., 12 (12), 2060-2064.
  • pH-dependent permeabilization of liposomes by poly(2-ethylacrylic acid). THOMAS, J. L., CHUNG, J., GROSS, D., and TIRRELL, D. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 36 (2), 156–157.
  • New synthetic amphiphilic polymers for steric protection of liposomes in vivo. TORCHILIN, V. P., TRUBETSKOY, V. S., WHITENIAN, K. R., CALICETI, P., FERRUTI, R., and VERONESE, F. NI. y. phann. sn., 1995, 84 (9), 1049–1053.
  • In vivo visualizing of organs and tissues with liposomes. TORCHILIN, V. P., and TRUBETSKOY, V. S. y. Liposome Res., 1995, 5 (4), 795–812.
  • The Microsphere Plate: a new type of electron multiplier. TREMSIN, A. S., PEARSON, J. F., LEES, J. E., and FRASER, G. IV. Nucl. Instrum. Methods Phys. Res., Sect A, 1996, 386 (3), 719–730.
  • Heat-stabilized albumin microspheres as a sustained drug delivery system for the anti-metabolite, 5-fluorouracil. TRUTER, E. J. A rtif. Cells Blood Substit. lmmobil. Biotechnol., 1995, 23 (5), 579–586.
  • Regulation of tetracycline hydrochloride release from polyacrylate microspheres. The mechanism of release. TSANKOV, S., LAmeov, N., and Mimcov, E. Pharm. Ind., 1995, 57 (12), 1044–1047.
  • Nonswellable and swellable ethylene glycol dimethylacrylate-acrylic acid copolymer micro-spheres. TUNCEL, A., ECEVIT, K., KESENCI, K., and PISKIN, E..7. Polym. Sci., Part A: Polym. Chem., 1996, 34 (1), 45–55.
  • Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation. UCHIDA, T., GOTO, S., and FOSTER, T. P. Pharm. Pharmacol., 1995, 47 (7), 556–560.
  • Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. UCHIDA, T., YAG I, A., ODA, Y., NAKADA, Y., and GOTO, S. Chem. Pharm. Bull., (Tokyo), 1996, 44 (1), 235–236.
  • Enhanced tumor targeting and improved antitumor activity of doxorubicin by long-circulating liposomes containing amphipathic poly(ethylene glycol). UNEZAKI, S., MARUYAMA, K., [SHWA, 0., SUGINAKA, A., HOSODA, J., and IwATsuat.r, M. Int. y. Pharm., 1995, 126 (1, 2), 41–48.
  • Effect and safety of liposome-encapsulated hemoglobin neo red cells (NRCs) as a perfusate for total cardiopulmonary bypass. USUBA, A., MOTOK I, R., OGATA, Y., Suzum, K., and KAMITANI, T. Artif. Cells Blood Substit. Immobil. Biotechnol., 1995, 23 (3), 337–346.
  • In vitro synthesis of an N-myristoylated fusion protein that binds to the liposomal surface. UTSLIMI, T., KURANAMI, J., Too, E., IDE, A., AKIMARU, K., HUNG, M. C., and KLOSTERGARRD, J. Arch. Biochem. Biophys., 1996, 326 (2), 179–184.
  • Prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin. VAAGE, J., DONOVAN, D., LOFTUS, T., and WORKING, P. Br. y. Cancer, 1995, 72 (5), 1074–1075.
  • Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant im muno-therapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. VAIL, D. M., MACEWEN, G., KURZMAN, I. D., DUBIELZIG, R. R., HELFAND, S. C., KISSEBERTH, W. C., LONDON, C. A., OBRADOVICH, J. E., MADEWELL, B. R., et al. Clin. Cancer Res., 1(10), 1165-1170.
  • Hyperthermia enhances tumor uptake and antitumor efficacy of thermostable liposomal daunorubicin in a rat solid tumor. VAN BREE, C., KROOSHOOP, J. J., RIETBROEK, R. C., KIP?, J. B., and BAKKER, P. J. Cancer Res., 1996, 56 (3), 563–568.
  • PCR monitoring of response to liposomal amphotericin B treatment of systemic candidiasis in neutropenic mice. VAN DEVENTER, A. J. M., GOESSENS, W. H. F., VAN BELKUM, A., VAN DrrEN, E. W. M., VAN VLIET, H. J. A., and VERBRUGH, H A. J. Clin. Microbiol., 1996, 34 (1), 25–28.
  • Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice. VAN ETTEN, E. W., TEN KATE, M. T., STEARNE, L. E., and BAKKER, W. I. A. Antlmicrob. Agents. Chemother., 1995, 39 (9), 1954–1958.
  • Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans. VAN ETTEN, E. W. NI., CHANDER, H. R., SNIJDERS, S. V., and BAKKER, W. I. A. J. NI. y. Antimicrob. Chemother., 1995, 36 (6), 961–974.
  • Kinetics of liposome disintegration from foam film studies: effect of the lipid bilayer phase state. VASSILIEFF, C. S., PANAIOTOV, I., MANEV, E. D., PROUST, J. E., and IVANOVA, T. Biophys. Chem., 1996, 58 (1–2)m 97–107.
  • Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats. VELINOVA, M., READ, N., KIRBY, C., and GREGORIADIS, G. Biochem. Biophys. Acta, 1996, 1299 (2), 207–215.
  • Exact solution of the Schroedinger equation for Wannier excitons on a microsphere. VIRI, D., and DEL SOLE, R. Solid State Commun., 1996, 97 (11), 985–989.
  • Preparation and characterization of dextran magnetite-incorporated thermosensitive lipo-somes: an on-line flow system for quantifying magnetic responsiveness. VIROONCHATAPAN, E., UENO, M., SATO, H., ADACHI, I., NAGAE, H., TAZAWA, K., and HORIKOSHI, I. Pharm. Res., 1995, 12 (8), 1176–1183.
  • Effect of composition and method of preparation of liposomes on their stability and interaction with murine monocytes infected with Brucella abortus. VITAS, A., DIAZ, R., and GAMAZO, C. Antimicrob. Agents Chemother., 1996, 40 (1), 146–151.
  • Peptide-mediated release of folate-targeted liposome contents from endosomal compart-ments. VOGEL, K., WANG, S., LEE, R. J., Low, P. S., and CHMIELEWSKI, J. J. Am. Chem. Soc., 1996, 118 (7), 1581–1586.
  • Antioxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits. WALTHER, F. J., DAvip, C., and LOPEZ, S. L. Am. y. Physiol., 1995, 269 (5 Pt 1), L613–L617.
  • Deviation of the ratio of drugs in a two-component mixture encapsulated in cellulose phthalate microspheres. WAN, L. S., Com, W. K. J. Microencapsul., 1995, 12 (4), 417–423.
  • Adverse effects at adjuvant treatment of liver metastases in rat with RSU-1069 + micro-spheres, or liposomal MTP-PE. WANG, L., Roos, G., STENRAM, U. Anticancer Res., 1995, 15 (5B), 2077–2080.
  • Antitumor effects of direct IL-2 gene transfer into tumor by liposome and its induction of local immune response. WANG, Q., CA0, X., ZHANG, W., ZHOU, Z., MA, S., and Y1E, T. Zhongguo Mianyixue Zazhi, 1995, 11(5), 290–293. 297.
  • Flameless atomic absorption spectrometric determination of cisplatin content in cisplatin chitosan microspheres for targeting drug delivery. WANG, Y., and SHI, T. Zhongguo Yaoxue Zazhi, 1995, 30 (10), 618–620.
  • Distribution of free and liposomal annamycin within human plasma is regulated by plasma triglyceride concentrations but not by lipid transfer protein. WASAN, K. NI., and PEREZ, S. R. J. Pharm. Sci., 1995, 84(9), 1094–1100.
  • Targeted liposomes in fungi: modifying the therapeutic index of amphotericin B by its incorporation into negatively charged liposomes. WASAN, K., and LOPEZ, B. G. J. Liposome Res., 1995, 5 (4), 883–903.
  • Toxic effects of antileishmanial reverse-phase evaporation liposomes containing dicetyl phosphate in monkeys. WASSEF, N. M., SWARTZ, G. M., BERMAN, J. D., WILHELMSEN, C. L., and ALviNo, C. R. Drug Delivery, 1995, 2 (3/4), 181–189.
  • In-vivo NMR thermometry with liposomes containing Co-59 complexes. WEBB, A. G., WoNo, M., NIESNIAN, M., KOLBECK, K. J., WILMES, L. J., MAGIN, R. L., and SUSLICK, K. S. mt. y. Hyperthermia, 1995, 11(6), 821–827.
  • Information resources for liposome research: the drug discovery program of the U.S. National Cancer Institute. WEINSTEIN, J. N., and MYERS, T. G. y. Liposome Res., 1995, 5(4), 837–844.
  • A primary x-ray investigation of the turning of ferroelectric microspheres contained in electrorheological fluids under a direct current electric field. WEN, W., and Lu, K. Appl. Phys. Lett., 1996, 68 (8), 1046–1047.
  • Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen. WHITE, W. L, CASSATT, D. R., MADSEN, J., BURKE, S. J., WOODS, R. M., Wasses, N. 1VI., ALviNo, C. R., and KOENIG, S. Vaccine, 1995, 13 (12), 1111–1122.
  • Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant-induced arthritis. WILLIAMS, A. S., CAMILLERI, J. P., Amos, N., and WILLIAMS, B. D. Clin. Exp. Immunol., 1995, 102 (3), 560–565.
  • Physicochemical characterization of the nisin-membrane interaction with liposome derived from Listeria monocytogenes. WINKOWSKI, K., LUDESCHER, R. D., and MONTVILLE, T. J. Appl. Environ. Microbiol., 1996, 62 (2), 323–327.
  • High-precision measurement of the swelling of microspheres. WIRONEN, J., SHEN, C., YAN, J., and BATICH, C. y. Appl. Polym, Sci., 59 (5), 825–830.
  • Pharmaceutical and biological properties of doxorubicin encapsulated in liposomes (L-ADM): the effect of repeated administration on the systemic phagocytic activity and pharmacokinetics. YACHI, K., KIKUCHI, H., SUZUKI, N., ATSUMI, R., AONUMA, M., and KAWATO, Y. Biopharm. Drug. Dispos., 1995, 16 (8), 653–667.
  • Distribution of liposomes containing mannobiose esters of fatty acids in rats. Yam, K., KIKUCHI, H., YAmAucui, H., HIROTA, S., and TOMIKAWA, M. J. microencapui., 1995, 12 (4), 377–388.
  • Cationic liposomes. YAGI, K. Tanpakushitsu Kakusan Koso, 1995, 40 (17), 2577–2582.
  • Gene transfer by cationic liposomes. YAGI, K. Igaku no Ayumi, 1995, 175 (9), 635–637.
  • Experimental and clinical trial of degradable starch microspheres (DSM) in treatment of hepatic neoplasm: part 2. Clinical study. YAMADA, T. Nippon Igaku Hoshasen Gakkai Zasshi, 1995, 55 (11), 732–738.
  • High-density (Th, U)02 pellet preparation by sol-gel microspheres pelletization and diluted-hydrogen sintering. YAMAGISHI, S., and TAKAHASHI, Y. y. Nucl. Mater., 1995, 227 (1 and 2), 144–149.
  • High-performance liquid chromatography of peptides on a microspherical carbon column. (V). Chromatography under the basic conditions and regeneration of carbon packings. YAMAKI, S., ISOBE, T., OKUYAMA, T., and SHINODA, T., Kuromatogurafi, 1995, 16 (4), 348–349.
  • Percutaneous internal maxillary arterial embolization with ethylcellulose microspheres. Results in an animal model. YANG, J., MA, X. C., ZOU, Z. J., Wu, Q. G., and WEI, S. L. Invest. Radial., 1995, 30 (6), 354–358.
  • Experimental studies on liposome encapsulation in cytotoxicity of tetrandrine. YANG, S., YANG, X., DU YINGHE., and ZENG, Z. Zhongcaoyao, 1995, 26 (9), 470–472.
  • Properties of a microencapsulated anaerobic adhesive/sealant having high strength GY-560. YANG, Y KUANG, Z., YANG, J., and ZHANG, X. Zhanjie, 1995, 16 (4), 9–11.
  • The use of liposomes in the therapy of liver disease. YAO, T., HUANG, L., and ZERN, M. A. Adv. Drug Delivery Rev., 1995, 17 (3), 239–246.
  • Adsorption of BSA on highly carboxylated microspheres—quantitative effects of surface functional groups and interaction forces. YooN, J. Y., PARK, H. YJ. H., and Km,W. S. y Colloid Interface Sci., 1996, 177 (2), 613–620.
  • Simple preparation and characterization of cationic liposomes associated with a monoclonal antibody against glioma-associated antigen (immunoliposomes). YOSHIDA, J., and MIZUNO, M. J. Liposome Res., 1995, 5 (4), 981–995.
  • Drug release from poly(dl-lactide) microspheres controlled by y-irradiation. YOSHIOKA, S., Aso, Y., and KOHMA, S. y. Controlled Release, 1995, 37 (3), 263–267.
  • Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative. YOUNG, L. H., HOWARD, M. A., Hu, L. K., Km, R. Y., and ORAGOUDAS, E. S. Arch. Ophthalmol., 1996, 114 (2), 186–192.
  • Immobilization of p-aminobenzamidine on polymerized liposome and its affinity adsorption for trypsin. Yu, K., SUN, Y., Hu, Z. D., and ZHOU, X. Z. Gaodeng Xuexiao Huaxue Xuebao, 1996, 17 (1), 77–80.
  • Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes. ZALIPSKY, S., HANSEN, C. B., OAKS, J. M., and ALLEN, T. M. J. Pharm. Sci., 85 (2), 133–137.
  • Mixed lymphocyte islet culture for assessment of immunoprotection by islet microencap-sulation. ZEKORN, T., ENDL, U., HORCHER, A., SIEBERS, U BRETZEL, R. G., and FEDERLIN, K. Transplant Proc., 1995, 27 (6), 3362–3336.
  • Effect of operation variables and monomers on the properties of polyamide microcapsules. ZHANG, M., Ni, P., and YAN, N. J. Microencapsul., 1995, 12 (4), 425–435.
  • Liposome capillary electrophoresis for analysis of interactions between lipid bilayers and solutes. ZHANG, Y., ZHANG, R., HJERTEN, S., and LUNDAHL, P. Electrophoresis, 1995, 16 (8), 1519–1523.
  • New characteristics of pauci-chain polystyrene microsphere. ZHAO, J., MING, W. H., Lu, X. L., WANG, C. C., and Fu, S. K. Gaodeng Xuexiao Huaxue Xuebao, 1995, 16(12), 1960–1963.
  • Preparation and properties of gelatin microspheres containing superoxide dismutase. Zou, G., Xu, C., Hu, P., and Li, P. Wuhan Daxue Xuebao, Ziran Kexueban, 1995, 41(4), 517–520.
  • Prelinical toxicity of liposome-incorporated annamycin: selective bone marrow toxicity with lack of cardiotoxicity. Zou, V., PRIEBE, W., STEPHENS, L. C., and PEREZ, S. R. Clin. Cancer Res., 1996, 1(11), 1369–1374.
  • Differential scanning calorimetric analysis of dipalmitoylphosphatidylcholine liposomes upon hydrolysis. ZUIDAM, N. J., and CROMMELIN, D. J. A. Int. J. Pharm., 1995, 126 (1, 2), 209–217.
  • Physical (in) stability of liposomes upon chemical hydrolysis: the role of lysophospholipids and fatty acids. ZUIDAM, N. J., Gouw, H. K., BARENHOLZ Y., and CROMMELIN, D. J. Biochim. Biophys. Acta, 1995, 1240 (1), 101–110.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.